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Chapter I 
Introduction  
1.1 Antimicrobial resistance 
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aquaculture relies on antibiotics to manage infectious disease. In each of these situations, the effects of the antibiotics extend beyond the site of use.[12]  In the past 70 years, people have accepted antibiotics as their right to obtain a prescription at the first signs of common infection or treat themselves with a handful of economical antibiotics. Although one cannot conceive a restoration of pre-antibiotic times, yet the overuse of these agents in man and animals is relentlessly driving us in that direction.  Over the last 30 years,  limited new types of antibiotics have been developed.[13, 14] As the use of conventional antibiotics rises, antimicrobial resistance patterns are developing which necessitates the continuous need for novel and more effective alternatives. One of the recent efforts in addressing this challenge lies within the study of nanotechnology. 
1.2 Introduction to nanotechnology and nanobiotechnology 
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biological structures or the actual use of biological building blocks and platforms to assemble nanostructures.[39, 40]  As already mentioned, there are two elemental assemblies to creating nanostructures: top-down and bottom-up. The bottom-up approach exploits biological structures and processes to create novel functional materials, biosensors and bioelectronics for various applications.[26, 41] In terms of top-down approach in nanobiotechnology, tools and processes of nano or micro fabrication to synthesise nanostructures with defined surface features are applied.[39] One of the key differences between nanotechnology and nanobiotechnology is that in the former, the dominant approach is top-down whereas in the latter, it is bottom-up. This multidisciplinary field covers a vast and diverse array of technologies encompassing engineering, physics, chemistry and biology. It is the combination of these fields that has led to the birth of a new generation of materials and methods of preparation.  
1.3 Nanomaterials: synthesis and applications 
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e)  Inert gas condensation: metals are evaporated in separate crucibles inside a high vacuum chamber filled with helium or argon gas. The evaporated metal atoms lose their kinetic energy and condense in the form of small crystals which accumulate on liquid nitrogen filled cold finger as a result of inert atomic collision with gas atoms in the chamber.[47]  Chemical reduction is the most common route in metal nanoparticle synthesis due to their facile protocols, fine shape and size control achieved.  The control of size, shape and stability of nanoparticles can be achieved by integrating different capping agents, solvents and templates. Capping agents utilised include simple ions to polymeric molecules and biomolecules.[48]  While physical and chemical approaches have dominated the synthesis of nanostructures, recently considerable attention is placed upon the application of biological systems. Biological systems are known to construct intricate structures at the nano and micro scale with precise control in normal environmental conditions. This property has attracted researchers to understand and discover the underlying mechanisms used by the biological systems and thus explore the biomimetic methodology towards nanomaterial synthesis. Biomimetic refers to the application of biological principles for materials formation. One of the primary processes in biomimetics involves bioreduction- the use of organisms such as bacteria, actinomycetes, fungi and plants to synthesise nanomaterials.[49-53]  
1.3.1 Metal nanoparticles  
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understanding their optical and electronic effects, metal nanostructures also offer an advantage over other systems as their optical constants resemble those of the bulk metal to exceedingly small dimensions (i.e. <5 nm).[54] Synthesis of metal nanostructures has been widely researched due to their interesting size and shape-dependent properties. These novel properties can be tailored by controlling their size, shape, composition, structure and crystallinity. Emphasis is placed on shape control as this allows optical, electronic, magnetic, catalytic and other properties of the nanostructures to be altered for versatile applications. Thus it has been established that the optical and electro-magnetic properties of a metal nanostructure is greatly dependent not only on the size of the structure, but also on the shape.[55-59]  The synthesis and properties of a number of different types of metal nanoparticles have been investigated. These include gold,[60-62] silver,[63-65] palladium,[66, 67] platinum,[68-70] titanium,[71-73] etc. Among these, gold and silver nanoparticles have been most commonly studied for diverse range of applications. This thesis focuses on exploring the potential of silver (Ag) nanoparticles for antimicrobial applications. 
1.3.2 Silver nanoparticles  
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decorative ornaments and as a biocide that first captivated the interest of early civilizations.  The applications of silver have advanced since the time of ancient Greece and Rome; this is primarily due to its distinctive electrical properties which promoted its first use in electrical devices. Since silver is identified to be among the best electrical and thermal conductors of all noble metals, it is widely used in conductors, switches, contacts and fuses.[79, 80] The most significant use of metallic silver in electronics has been in the preparation of thick-film pastes, typically in pure silver-palladium formulations for use in silk screened circuit paths, multi-layer ceramics capacitors and conductive adhesives.[81]  
1.4 Antimicrobial applications of Ag nanoparticles 
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to optimise the active sites on the nanoparticle surface i.e. hydrophilic, hydrophobic, conductive etc.[109] It can be broadly classified into two categories, non-covalent binding physisorption or covalent binding chemisorption. In terms of physisorption, the binding is fairly weak where the ligand and the nanomaterial are bound through weak electrostatic interactions, hydrogen bonding and or hydrophobic interactions. This nature of surface functionalisation is beneficial for forming the surface coatings for stabilising individual nanoparticles in solution. In contrast, chemisorption is greater than the non-covalent bonds formed by physisorption. The majority of the surface functionalisation methods are based on covalent bond formation. This technique provides a stronger bond which allows the ligand to be more stable on the surface which makes the linkage robust. Functional groups present on the ligand react with the substrate material and chemisorb onto the nanomaterial surface to yield self-assembled structures.[110-112]  Surface modification of nanoparticles may generate novel and interesting opportunities to develop efficient antimicrobial agent. To this end, nature has developed unique protein-based effective antibacterial platforms including lysozyme and antimicrobial peptides to control bacterial growth.[113-115] These natural antibacterial applications normally cause bacterial cell lysis and hence microorganisms find it challenging to gain resistance against these biologically nature produced antibiotics.  
1.5 Distinctive features of the bacterial cell 
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and are normally 0.5 to 5.0 µm in length.[116] Bacterial outer envelope that protects it from the external environment can have the following structural characteristics: 
 Polysaccharide membrane (capsule) 
 Lipid bilayer (outer membrane) 
 Peptidoglycan (cell wall)  
 Periplasmic space  
 Periplasmic membrane (cytoplasmic plasma membrane) Bacteria can possess different cell wall structures on the basis of their Gram stain. This staining technique was founded by Hans Christian Gram to distinguish bacteria into two major categories based on their response to the Gram stain procedure. In a Gram stain test, Gram positive bacteria would retain the crystal violet dye purple while a counterstain added to the crystal violet produces Gram negative bacteria a red or pink stain.[117, 118] The structural difference between Gram negative and Gram positive bacteria is also in the organisation of peptidoglycan layer which is the key component of the cell wall.[119]  
1.5.1 Structure of Gram negative and Gram positive bacterial cell  
The cell walls of bacteria consist of covalently linked polysaccharide and polypeptide chains which form a round macromolecule that entirely encases the cell. This framework is known as peptidoglycan, a polymer composed of two sugar derivatives: 
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linked peptidoglycan are connected by cross linkers between peptides while the carboxylic group of the terminal D-alanine is attached directly to the amino group of diaminopimelic acid. In addition, a peptide inter-bridge may be an alternative option, however most Gram negative cell wall peptidoglycan lacks the peptide inter-bridge.[120, 121]  Illustrated in Figure 1.1 is the schematic representation of Gram positive and Gram negative bacteria. In the case of Gram positive bacteria, it consists of a thick multilayered cell wall composed of peptidoglycan surrounding the cytoplasmic membrane. In addition, a peptide inter-bridge and greater amount of teichoic acids (polymer of glycerol or ribitol joined by phosphate groups) exists. Amino acids such as D-alanine are attached to the glycerol and ribitol groups. Teichoic acid is covalently linked to muramic acid and connects various layers of the peptidoglycan mesh together. Teichoic acid may prevent extensive wall breakdown and cell lysis during cell growth and is the provider of the cell wall’s antigenicity.[120]  
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Figure 1.2 – Schematic representation of Gram positive and Gram negative bacteria.   One of the main objectives of the work presented in this thesis is to investigate the interactions between different silver nanostructures and various bacterial strains.  Therefore, well established model microorganisms Staphylococcus albus (S. albus) and 
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sulphated polysaccharide. The gene icaADBC is responsible for both the polysaccharide capsule and the polysaccharide intracellular adhesion used in biofilm formation. This allows other bacteria to bind to the already existing biofilm, which in turn produces a multilayer biofilm. The metabolic activity of bacteria within is therefore decreased. This film is adhesive to hydrophobic biopolymers of prosthetics, creating diseases such as endocarditis.[123, 124]  
E. coli is a Gram negative, rod shaped bacterium of the genus Escherichia which is typically found in the lower intestine of warm blooded organisms. Most E. coli strains are harmless however some strains may cause severe food poisoning in their hosts and are seldom liable for food contamination.[125] Some E. coli cause disease by producing a toxin called Shiga toxin. Thus the bacteria that create these toxins are known as “Shiga toxin-producing” E. coli or STEC. The most common type of STEC is E. coli O157:H7 which causes severe, acute haemorrhagic diarrhoea and abdominal cramps.[126, 127]  These bacteria were chosen as they are well understood and these are an important model organism in a number of fields of research, particularly genetics, molecular biology and biochemistry. The bacteria are easy to grow under laboratory conditions and strains are relatively safe to work with.  
1.6 Rationale of thesis 
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c) A non-toxic green synthesis of functionalised Ag nanoparticles using phenolic compounds (e.g. phytochemicals or amino acids) to enhance antibacterial activity due to antioxidant corona layers (Chapter V).  d) Investigation of new interdisciplinary techniques to understand the role of surface corona and Ag nanoparticle shape on antibacterial activity (Chapter VI). 
1.7 Outline of thesis 
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electrochemical and biological techniques helped in proposing potential mechanisms of Ag nanostructures and their ability to interact with Gram negative and Gram positive bacterial cells. Last but not the least, Chapter VII summarises the overall outcome of the thesis and proposes some of the future work that may be built upon the outcomes obtained from this study. 
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Characterisation Techniques  
2.1 Introduction  





This chapter is devoted to the physical principles and instrumentation of the various characterisation techniques used in this thesis which have been elaborated further below.  
2.2  Fourier transform infrared spectroscopy (FTIR) 







 +=  (2.1) 
The vibrational quantum number n= 0,1,2,... is a positive integer and v0 is the characteristic frequency for a particular normal mode. In accordance with the selection 





simultaneously followed by a mathematical analysis of the signal output. This is called a 
Fourier transformation, where it is used to convert the detected signal back into the classical form of the spectrum. Thus the resulting signal is known as a Fourier transform infrared (FTIR) spectrum.  In contrast to classical spectrometers, where the spectral absorption of a sample is being scanned, FTIR spectroscopy is an interferometric method. A FTIR spectrometer consists in principle of an infrared source, an interferometer, the sample, and the infrared detector.  
 





2.2.1 Attenuated total reflection infrared spectroscopy (ATR-IR) Attenuated total reflection infrared (ATR-IR) spectroscopy is employed for the analysis of the surface of materials. It is also often suitable for characterisation of materials which are too condensed to be analysed by transmission spectroscopy. The experimental setup of the internal reflection technique is shown in Figure 2.2. 
 
Figure 2.2- Attenuated total reflection experimental setup. For ATR-IR, the infrared light passes through an optically dense crystal and reflects at the surface of the sample. According to Maxwell’s theory, the propagating light passing through an optically thin, non-absorbing medium forms a standing wave, perpendicular to that of the total reflecting surface.[3] When the sample absorbs a fraction of this radiation, the propagating wave interacts with the sample and becomes attenuated. The reflectance R of the attenuated wave can be expressed as: 













Where λ0 is the wavelength of light in the internal reflection crystal, θ is the angle of incidence, and n21 is the reflective index ratio of the sample and crystal.  Characterisation of silver nanoparticles was achieved by using Perkin Elmer Spectrum 100 to define functional groups present. An initial background for energy match was run at 16 scans per spectrum. Spectra were obtained by accumulating 16 scans per spectrum in the ranges from 4000 cm-1 to 850 cm-1.  
2.3  X-ray photoelectron spectroscopy (XPS) 
 X-ray photoelectron spectroscopy (XPS) provides chemical information regarding the surface of a specimen. The XPS functions by bombarding a surface with x-rays and recording the energy of ejected electrons. These characteristic electrons are ejected from the top most layers of the surface, typically nanometres in depth, and are used to identify the source element and immediate environment of components. Thus the energy of electrons measured at the detector is used to distinguish which elements are present and how they are bound. This is described by binding energy (BE) in an XPS spectrum.[4] When an x-ray of known energy hv interacts with a surface, an electron is described as being ejected assigned EB (binding energy) giving the following equation observing the conservation of energy:[4] 





2.4  Ultraviolet visible spectroscopy (UV-Vis) 
Ultraviolet-Visible spectroscopy (UV-Vis) is a reliable and accurate analytical technique that allows for the quantitative analysis of a material. Specifically, UV-Vis measures the absorption, transmission and emission of ultraviolet and visible light wavelengths by matter.[5] When a beam of electromagnetic radiations strikes an object, it can be absorbed, transmitted, scattered, reflected or excite fluorescence. The processes of interest in the absorption spectroscopy are absorption and transmission. When a sample is observed for absorption, conditions are undertaken to maintain reflection, scatter and fluorescence to a minimum.[6] An optical spectrometer records the wavelengths at which absorption occurs as well as the degree of absorption at each wavelength.  The energy associated with a given fragment of the spectrum is proportional to its frequency. The following equation depicts this correlation, which provides the energy carried by a photon of a given wavelength of radiation.  
𝐸 = ℎ𝑣 = ℎ𝑐
𝜆
 (2.5) 





                        
Figure 2.3- Components of a typical UV-Vis spectrometer. 
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2.4.1  Surface plasmon resonance (SPR) Surface plasmons are essentially the light waves that are trapped on the surface due to interactions with free electrons of the metal.[7] When metal nanoparticles are implanted in a dielectric medium and specimen are exposed to electromagnetic radiation, SPR absorption band is observed at a specific wavelength (Figure 2.4). This is chiefly dependent upon the nature of the metal, size and distribution of the particles including several other factors.[6]  
 





2.5 Atomic absorption spectroscopy (AAS) 
 Atomic absorption spectroscopy (AAS) is an analytical procedure for the qualitative detection and quantitative determination of elements through the absorption of optical radiation by free atoms in the gas phase.[12]   Atomic absorption obeys the Beer Lambert law, which states that absorbance (denoted as A, negative logarithm of the transmission factor) is proportional to the concentration c of the absorbing substance and the thickness d of the absorbing layer:  
( )




log  (2.7) 
Where Фt is the power of transmitted radiation and Фi is the power of incident radiation. Concentrations of samples were determined by Perkin Elmer Atomic Absorption Spectrometer 3110 (Cary 1).   
2.6 Electron microscopy  
Spectroscopic techniques can provide information on chemical nature of nanostructures, however, direct imagining of specimens can only be made possible via electron microscopes- transmission and scanning electron microscopes. Similar to light microscopy, where the resolution of the acquired image is dependent on the wavelength of light, electron microscopes uses beam of electrons to create such image. It is capable of much higher magnifications and has a greater resolving power than that of a light microscope, allowing one to see much smaller specimens in finer detail.   





understanding of morphological fine structural details. A modern TEM provides the capability to directly image atoms in crystalline specimens at resolutions close to 0.1 nm, which is of the order of interatomic distances.    Electron beam instruments are operated under high vacuum to avoid dispersion of electrons from the air molecules due to high voltage. A TEM is operated under vacuum, equipped with an electron gun capable of accelerating electrons through a potential difference in the range of 60 to 400kV.  
 2.6.1.1 Image formation TEM is simplified into a single-lens microscope, as shown in Figure 2.6, in which only a single objective lens is considered for imaging. The intermediate lenses and projection lenses are omitted. This is due to the resolution of the TEM being primarily determined by the objective lens.[14] The entrance surface of a thin foil specimen is illuminated by a parallel beam. The electron beam is diffracted by the lattices of the crystal, forming the Bragg beams that are propagated along different directions.[15] The electron interaction results in phase and amplitude changes in the electron wave that are determined by quantum mechanical diffraction theory.[16]  
 





All TEM images in this thesis were obtained using a JEOL-1010 TEM operating at an accelerating voltage of 100kV. Samples were prepared by drop casting sample onto strong carbon coated 200 mesh copper grids and allowed to evaporate before TEM imaging. 
2.6.2  Scanning electron microscope (SEM) 





due to elastic and inelastic scattering interaction within the surface. High energy electrons that are ejected by an elastic collision of an incident electron are referred to backscattered electrons.[18]    SEM images presented within this thesis were obtained by using Philips XL30 SEM. Samples were drop cast on polished silicon wafers attached to SEM stub via carbon tape. The samples were then coated with a thin layer of platinum deposition via precision etching coating system (PECS), Gratan model 682 to minimise sample charging. The coatings were prepared at a rock angle of 20°, speed 40°/sec, rotation of 25 rpm and beam current of 5 KeV.  
2.7 Dynamic light scattering (DLS) 





𝑑(𝐻) = 𝑘𝑇3𝜋𝜂𝐷 (2.8) Where d(H) is the hydrodynamic diameter, d  is the translational diffusion coefficient, k is Boltzmann’s constant, T is absolute temperature and η is the viscosity.   The diameter measured in DLS is a value that refers to how a particle diffuses within the fluid and is referred to as a hydrodynamic diameter. The diameter obtained by this technique is the diameter of a sphere that has the same translational diffusion coefficient as the particle.   The translational diffusion coefficient is determined by not only the size of the core of the particle, but also on any surface structure as well as the concentration and type of ions in the medium. Factors that affect the diffusion speed of particles are ionic strength of medium, surface structure and non-spherical particles. Therefore, the hydrodynamic diameter measured in DLS can often be larger than that measured by electron microscopy.   All DLS measurements were carried out on an ALV 5022F Fast DLS particle sizing spectrometer at 22°C with a fixed angle of 90° on highly diluted aqueous samples.  
2.8  X-ray diffraction (XRD) via general area detector diffraction 
system (GADDS) 





wavelength interact elastically with the regular arrays of atoms in a crystal lattice to yield a diffraction pattern.[21] Diffraction angles and the intensities in various diffracted beams are a receptive function of the crystal structure. The diffracted angles are dependent upon the lattice and the unit cell dimensions, while the diffracted intensities are dependent upon the atomic numbers of the constituent atoms and geometrical relationship with the lattice points.  A convenient form of the geometrical relationship determining the angular distribution of the peak intensities in the diffraction pattern is the Bragg’s equation:[22]  
θλ sin2dn =  (2.9) Where n is an integer referring to the order of reflection, λ is wavelength of the radiation, d is the spacing between crystal lattice planes and θ is the angle of the incident beam.   
 





2.8.1 General area detector diffraction system GADDS is a micro X-ray diffraction system which utilizes a high sensitivity 2D area detector. GADDS has the capability to analyse a selected spot on the surface of a sample, where the instrument focuses an x-ray beam to a spot as small as 60 µm.[23] Samples are usually fixed on a moveable x,y,z stage and for the investigation of a specific area, the sample is orientated in the x-ray beam via a CAD camera and a laser beam.  Powder XRD data was obtained using Bruker Axis D8 Advance Powder Diffractometer with a GADDS micro diffraction instrument over a 2θ range of 15-85°. 
2.9 Electrochemical studies using cyclic voltammetry  
The oxidation and reduction involving electron transfer can be described as follows: 





When carrying out a cyclic voltammogram (CV), an initial potential is applied to the working electrode and is ramped positively at a sweep rate of 50 mV s-1 to a predetermined switching potential, at which the ramping direction is reversed. This is illustrated in Figure 2.7 where (A) shows the potential ramping profile whilst (B) shows the corresponding CV (current response) to the profile.[25]  
 
Figure 2.7- (A) Applied potential regime and (B) the corresponding cyclic voltammogram. 
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Chapter III 
Influence of the morphology of silver nanoparticles on antibacterial activity: spheres, cubes and prisms 
 
3.1 Introduction 
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antimicrobial agent. It is notable that silver ions (Ag+) are well known to possess strong inhibitory and antibacterial effects as well as a broad range of antimicrobial activities.[21-23] However, it is relatively recent that various researchers have started investigating the antimicrobial capabilities of silver nanoparticles (Ag0). Most of these studies on Ag nanoparticles based antimicrobial agents have been restricted to the use of spherical Ag nanoparticles against Gram negative and or Gram positive bacteria.[2, 21, 23, 24] Relatively few reports have investigated shape-dependent antimicrobial efficacy of Ag nanoparticles. However, contamination of samples with different Ag shapes in such studies makes it difficult to precisely understand the role of Ag nanoparticle shape in causing antimicrobial activity.[22] Considering that size as well as shape of Ag nanoparticles may have considerable effect on their properties, this chapter has undertaken the task of studying the shape-dependent antibacterial properties of Ag nanoparticles. The main focus on this chapter is to particularly investigate the comparison of different shapes of nanoparticles (spherical, cubic and prismatic) against representative strains of Gram negative and Gram positive bacteria. 
3.2 Experimental  
3.2.1 Synthesis of Ag nanospheres 
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sulphate (containing 2 x 10-3 M equivalent of Ag+ ions) was prepared and added to 20 mL of 10-3 M aqueous solution of tyrosine. This solution was then diluted to 100 mL with Milli-Q water. To this solution, 1 mL of 10-1 M KOH was added and allowed to boil. Within 20 minutes the initial colourless solution changed into a light yellow colour which indicated the formation of silver nanoparticles. The solution was allowed to boil for a further 15 minutes for silver nanoparticles to grow and stabilise.  
3.2.2 Synthesis of Ag nanocubes 
Silver nanocubes were synthesised via a procedure outlined by Xia et al.[26] This synthesis was achieved by mediating a polyol process which is simple, robust and versatile in the formation of monodispersed silver nanocubes. In a typical experiment, silver cubes are produced by reducing AgNO3 with ethylene glycol (EG) through the subsequent mechanism: 
2𝐻𝑂𝐶𝐻2 𝐶𝐻2 𝑂𝐻 →  2𝐶𝐻3𝐶𝐻𝑂 + 2𝐻2𝑂
 
 (3.1) 
2𝐴𝑔+ + 2𝐶𝐻3 𝐶𝐻𝑂 → 𝐶𝐻3 𝐶𝑂 ─ 𝑂𝐶𝐶𝐻3 +  2𝐴𝑔0 + 2𝐻+ (3.2) 
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3.2.3 Synthesis of Ag nanoprisms 
Silver nanoprisms were synthesised via a procedure outlined by Aherne et al.[27] by a reproducible seed-based thermal method. The method was modified through the adjustment of reaction conditions and included following steps: 
3.2.3.1 Seed production: 
Silver seeds were produced by combining aqueous trisodium citrate (5 mL, 2.5 mM), aqueous poly(sodium styrenesulphonate) (PSSS - 0.25 mL, 500 mgL-1; Aldrich 1,000 kDa) and aqueous NaBH4 (0.3 mL, 10 mM, freshly prepared) followed by addition of aqueous AgNO3 (5 mL, 0.5 mM) at a rate of 2 mL min-1 while continuously stirred. 
3.2.3.2 Nanoprism growth: 
Nanoprisms were synthesised by increasing 5 times the concentration of the originally reported experiment; specifically, nanoprisms were produced by the combination of 10 mL Milli-Q water, 75 μL of aqueous ascorbic acid (50 mM), 400 μL seed solution, followed by the addition of 3 mL aqueous AgNO3 (2.5 mM) solution at a rate of 1 mL min-1. To stabilize the nanoprisms 0.5 mL of aqueous trisodium citrate (125 mM) was added after the experiment.  
3.2.4 Quantification of Ag nanoparticles by atomic absorption 
spectroscopy (AAS) 
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analysis, all Ag nanoparticles were centrifuged three times against Milli-Q water for 15 minutes at 12,000 rpm to remove free Ag+ ions. Ag nanoparticles were initially dissolved in nitric acid and calibration standards were prepared using 1000 ppm stock solution of silver nitrate. Based on Ag standards, calibration graph was created and concentrations of Ag nanoparticles were determined. Samples were then diluted to desired concentrations for use.  
3.2.5 Antibacterial applications 
 All antibacterial experiments were performed under sterile conditions in a laminar flow cabinet. Before the commencement of microbiological experiments, media cultures, glassware and pipette tips were sterilised by autoclaving at 121°C for 15 minutes. Gram negative Escherichia coli (E. coli) and Gram positive bacterium 
Staphylococcus albus (S. albus) were used as microorganisms for antibacterial applications.  
3.2.5.1 Colony forming units (CFU) assay 
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3.2.5.2  Liquid broth growth kinetic assay  
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3.3 Results and discussion 
3.3.1 UV-Visible spectroscopy studies of Ag nanoparticles 
The optical absorption spectra of metal nanoparticles are dominated by surface plasmon resonance (SPR), which shifts to longer wavelengths with increasing particle size.[28] The shape and position of plasmon absorption of silver nanoclusters are highly dependent on the particle size, shape, dielectric environment and surface adsorbed species.[29] In Mie’s theory,[30] only a single SPR band is expected to be present in the absorption of spherical nanoparticles, whereas anisotropic particles could give rise to two or more SPR bands depending on the shape of the particles. The number of SPR peaks increases as the symmetry of the nanoparticles decreases,[31] hence different shaped nanoparticles of silver may show one, two or more peaks. 
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sharp SPR feature at 428 nm indicating monodispersity of the sample without any anisotropic features.[25]  Similarly, a SPR maximum of Ag nanocubes at 420 nm is consistent with that of previous studies wherein SPR maximum was found to blue-shift with the reduction in edge length and 40 nm sized nanocubes with rounded edges lead to SPR maximum at ca. 425 nm.[32] Conversely, Ag nanoprisms show three dominant SPR peaks in the UV-Vis spectrum that are typical of Ag nanoprisms, and arise due to in-plane dipolar excitation (most intense red-most band at 700 nm), in-plane quadrupole excitation (middle band at 400 nm), and out-of-plane quadrupole excitation (bluest resonance at 335 nm).[27, 33] 
3.3.2 TEM and DLS measurements of Ag nanoparticles  
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along with standard distribution to be 21.8 ± 5.0 nm (diameter), 48.7 ± 9.3 nm (edge length) and 30.5 ± 10 nm (edge length) for spheres, cubes and prisms respectively. 
 
Figure 3.2- TEM images and corresponding particle size distribution histograms of (A) Ag nanospheres, (B) Ag nanocubes and (C) Ag nanoprisms. Dynamic light scattering (DLS) is a well-established technique to determine the size distribution profile of nanoparticles that provides information about the hydrodynamic radii of nanoparticles in solution by measuring the time scale of light intensity fluctuations. Hence, to confirm the hydrodynamic radii of nanoparticles in solution, DLS analysis was carried out on all Ag nanostructures.  
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DLS measurements in Figure 3.3 revealed that the trend in change of the average hydrodynamic radius corroborates with TEM diameter measurements. The average hydrodynamic radius was 41.4 nm in Ag nanospheres (equivalent to hydrodynamic diameter 82 nm), 69.6 nm (equivalent to hydrodynamic diameter 140 nm) in Ag nanocubes and 22.8 nm (equivalent to hydrodynamic diameter 45 nm) in Ag nanoprisms. Although DLS reveals a significantly higher particle size than those measured using TEM, this is expected because TEM reveals the physical size of high contrasting Ag component while DLS reveals hydrodynamic size taking surface capping into account.   
3.3.3 X-ray diffraction (XRD) studies of Ag nanoparticles 
Silver crystallites are in a cubic packed structure (FCC- face centred cubic), wherein the unit cell structure consists of the same length in all sides and all the faces are perpendicular to one another (Figure 3.4A). Silver atoms are present at each corner and in the centre of each face of the unit cell. Therefore, this unit cell is referred to as a face-centered cubic (fcc) unit cell.  
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flat-lying Ag nanoprisms predominantly covered by (111) fcc faces.[27] The (311) plane observed in the XRD pattern of Ag nanoprisms is also typically observed in flat fcc metal nanostructures, thus confirming the flat sheet-like morphology of Ag nanoprisms.[27] Additionally, two further peaks corresponding to reflections that were recently predicted to arise from a hexagonally closed pack (hcp) arrangement of Ag atoms was observed (dotted lines in Figure 3.4B). The hexagonal arrangement of Ag atoms is believed to propagate perpendicular to the flat (111) face of the nanoprism, resulting in a layered defect structure within the nanoprism.[27]   
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3.3.4 FTIR analysis of Ag nanoparticles 
3.3.4.1 FTIR analysis of Ag nanospheres 
The structure of the amino acid tyrosine used during the synthesis of Ag nanospheres is shown in Figure 3.5. Tyrosine consists of three main functional groups: phenolic, amine and carboxylic. 
 
Figure 3.5- Functional groups within tyrosine molecule.  Tyrosine was used as a reducing agent under alkaline conditions to reduce Ag+ ions for the synthesis of stable Ag nanospheres in aqueous solution. Ag+ ion reduction occurs at high alkaline pH, therefore tyrosine is a pH-dependent reducing agent. The pH -dependent reducing ability of tyrosine is shown to arise due to ionization of the phenolic group of tyrosine at high pH which by electron transfer to silver ions, is transformed to quinone (Figure 3.6).[25]  
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pure tyrosine. However, there is an apparent shift in vibrational frequency towards 1624 cm-1 after oxidation of tyrosine (Figure 3.7). Notably, this shift in the vibrational frequency of carbonyl stretching has been previously attributed to the formation of a quinone type structure due to the oxidation of the phenolic group in tyrosine.[25] 
 
Figure 3.7- FTIR spectra of pure tyrosine and tyrosine-reduced Ag nanospheres. The broad O-H peak in the tyrosine reduced Ag nanospheres at 3400 cm-1 to 3200 cm-1 is due to water molecules apparent in the sample. Absence of vibration signals of N-H bend and C-O stretch in Ag nanospheres compared to pure tyrosine suggests those functional groups have been involved and/or utilized during synthesis of Ag nanoparticles.  
Table 3.1- Summary of functional groups in tyrosine and tyrosine-reduced Ag nanospheres. 
Wavenumber (cm-1) Bond Functional group Appearance 
Tyrosine 3640 - 3200 H- bonded Phenolic vibrations Broad 1609 C=O stretch Carboxylic acid Narrow and sharp 1591 N-H bend 1 ˚ amine Narrow and sharp 1450 - 1300 C-H stretch Alkanes Narrow 
Tyrosine-reduced Ag nanospheres 3400 - 3200 O-H stretch Hydroxyl Broad 1624 C=O stretch Carboxylate ion Narrow and sharp 
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3.3.4.2  FTIR analysis of Ag nanocubes  
 Silver nanocubes were synthesized via a polyol-mediated process. The primary reaction of this process involves the reduction of an organic salt (the precursor) by polyol at an elevated temperature.[35] Polyvinylpyrrolidone (PVP) is normally added as a stabilizer to prevent agglomeration of the colloidal particles. The structure of the precursors used in this study has been shown in Figure 3.8. Table 3.2 provides a summary of the different vibrational bands present in PVP, EG, Ag nanocubes, and washed Ag nanocubes respectively. 
 
Figure 3.8- Structure of precursors EG (left) and PVP (right) employed for Ag nanocubes synthesis. FTIR spectra of precursors and Ag nanocubes are shown in Figure 3.9. The precursors for FTIR studies were PVP and EG. The polyol process is based on EG, which serves as an excellent solvent for PVP due to its relatively high dielectric constant.[36, 37] At high temperatures, EG can reduce Ag+ ions into Ag atoms and thereby induce the nucleation and growth of silver nanostructures in the solution phase. PVP plays a critical role in the formation of nanostructures, possessing efficient stability and size/shape uniformity.  
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from 3000 cm-1 to 2800 cm-1 indicate C-H stretching vibration modes of alkanes within PVP, EG, and Ag nanocubes.  
It is also evident from Figure 3.9 that PVP plays a critical role in the formation of silver nanocubes, as is clear from the comparison of the spectra of PVP and Ag nanocubes washed (peak shift and sharpening ca. 1600 cm-1). PVP molecules have been shown to preferentially adsorb onto the surface of silver particles, thus stabilizing the small single crystal Ag seeds.[32, 36] This also supports that EG acts as a solvent during the synthesis of Ag nanocubes, while PVP acts as a shape promoting and stabilizing agent, which leads to the formation of Ag nanocubes. 
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Table 3.2- Summary of functional groups in PVP, EG and Ag nanocubes. 
Wavenumber (cm-1) Bond Functional group Appearance 
Polyvinylpyrrolidone 3400 - 3600 O–H stretch Hydroxyl Broad 2900 - 2800 C–H stretch Alkane Broad 1660 C= O stretch Aromatic ketone Broad 1470 - 1450 C H bend Alkane Medium 1250 - 1020 C–N stretch Aliphatic amine Medium 900 - 800 Vinyl Monosubstituted alkene Medium 
Ethylene glycol 3300 O-H stretch Hydroxyl Broad 2900 - 2800 C-H stretch Alkane Medium 1470 - 1450 C-H bend Alkanes Medium 1110 - 1000 C–O stretch Primary alcohol Strong 
Ag nanocubes  3600 - 3000 O-H stretch Hydroxyl Broad 1660 C=O stretch Aromatic ketone Broad 
3.3.4.3 FTIR analysis of Ag nanoprisms 
Silver nanoprism synthesis is a seed-based thermal synthetic procedure that selectively produces Ag nanoprisms in a rapid and reproducible manner at room temperature. This method involves the silver seed catalysing a reduction of Ag+ by ascorbic acid. One of the key precursors for production of high quality Ag nanoprisms is the use of PSSS, which is used as a stabiliser in the seed production stage. The structures of PSSS and ascorbic acid are shown below in Figure 3.10.  
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Illustrated in Figure 3.11 is the FTIR spectra of precursors used in the synthesis, Ag seed as well as Ag nanoprisms. The frequencies observed at 1700 cm-1 to 1560 cm-1 in the case of PSSS are aromatic alkenes with HC=CH stretching. Since PSSS is used in the synthesis of Ag seeds, a shift at 1635 cm-1 in the case of Ag seeds is apparent. This shift suggests binding of PSSS to seed Ag nanoparticles. Similarly, a shoulder peak can be observed in the case of Ag nanoprisms at 1635 cm-1. Therefore, direct evidence for the utilisation of PSSS and the Ag seed during the synthesis of Ag nanoprisms is observed.  
 
Figure 3.11- FTIR spectra of precursors, Ag seed and Ag nanoprisms.  It is also evident that ascorbic acid plays a vital role in the formation of Ag nanoprisms with a peak at ca. 1750 cm-1  within the ascorbic acid spectrum representing C=O, and a shift in the frequency to ca. 1726 cm-1 in the Ag nanoprisms spectrum. Moreover, nitrate frequencies at 1398 cm-1 and 1356 cm-1 present in 
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Ag nanoprisms suggests that AgNO3 have also been involved and NO3- potentially remain bound to Ag nanoprisms post synthesis.  Broad O-H peaks at ca. 3600 cm-1 to 3000 cm-1 are present in ascorbic acid, Ag seed and Ag nanoprisms which are attributed to water molecules apparent within the samples. Table 3.3 provides a summary of the various vibrational bands present in all the precursors used in the synthesis as well as Ag seed and Ag nanoprisms.  
Table 3.3- Summary of functional groups in ascorbic acid, PSSS, AgNO3, Ag seed and Ag nanoprisms. 
Wavenumber (cm-1) Bond Functional group Appearance 
Ascorbic acid 3550 - 2950 O–H stretch Hydroxyl Broad 1750 C=O Aldehyde/Ketone Weak 1660 C=C stretch Aromatic ketone Strong 1443 C-H scissor Alkane Weak 1300 C–H bend Alkane  Medium 
PSSS 3600 - 3100  R–SO3stretch Ionic sulphonate Sharp 1700 - 1560 HC=CH stretch Aromatic alkene Weak 
AgNO3 1296 NO3 Nitrate Broad 
Ag seed 3600 - 3000 O-H stretch Hydroxyl Broad 1635 HC=CH stretch Aromatic alkene Broad 
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3.3.5  Antibacterial study of Ag nanoparticles against microorganisms  
3.3.5.1 Colony count studies  
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Figure 3.12- CFU expressed in percentage cell death (A) Ag nanoparticles against Gram negative E. coli and (B) Ag nanoparticles against Gram positive S. albus.  Therefore, it can be inferred from the CFU assay that Ag nanocubes perform significantly better than Ag nanoprisms and nanospheres in terms of antibacterial activity against both Gram negative and Gram positive bacteria. These findings suggest that different shape of Ag nanoparticles can considerably influence their antibacterial 
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behaviour and via controlling the shape of Ag nanoparticles, it might also be possible to control the growth of both Gram negative and Gram positive bacterial species.   
3.3.5.2 Antibacterial growth kinetics studies 
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B A 
Ag nanocubes therefore indicates cytolytic activity of Ag nanocubes. Whereas Ag nanospheres could only exhibit growth inhibition within this time frame.  
 
Figure 3.13- Growth kinetic profiles of (A) E. coli and (B) S. albus. Interestingly, Ag nanocubes were found to be significantly more effective in delaying the growth of Gram positive bacteria S. albus as evident in Figure 3.13B. The difference between the control and Ag nanospheres curves were not that significant compared to the effectiveness of Ag nanocubes. Therefore, Ag nanocubes are definitely more effective than Ag nanospheres as they are found to intensively delay the growth of Gram positive bacteria. 
3.3.6 SEM of bacterial cells after treatment of Ag nanostructures 
To understand the behaviour of bacteria on exposure to Ag nanoparticles, scanning electron microscopy (SEM) images of bacteria before and after exposure to Ag nanoparticles were obtained as shown in Figures 3.14 and 3.15. In the case of E. coli, Figure 3.14A shows untreated cells which appear smooth. When cells are exposed to Ag nanostructures (Figures 3.14B and D), cell walls show signs of rupture.  In comparison to untreated E. coli cells against treated cells with Ag nanoparticles, the images reveal 
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distinct changes in cell morphology, with pitting occurring where Ag nanoparticles are present. It is evident that there is a breakdown of cells as well as aggregation of Ag nanoparticles with the treatment of Ag nanocubes (Figure 3.14C). In the case of Ag nanospheres and Ag nanoprisms (Figure 3.14 B and D) exposure to E. coli promotes breakdown of the cell wall with less Ag nanoparticle aggregation observed on the bacterial surface in the case of Ag nanoprisms.  
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observed in Figure 3.15B with the treatment of Ag nanospheres reveals comprehensive breakdown and damage to the bacterial cell integrity. Furthermore, it could be seen that treated S. albus upon exposure of Ag nanocubes (Figure 3.15C) showed cells dissolving and their cellular components being released. Additionally, the components of S. albus bacteria cell wall displayed disorganised and scattered arrangement after the exposure of Ag nanoprisms in Figure 3.15D.  
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Figure 3.16- Schematic illustration of potential mechanisms of antibacterial activity of Ag nanostructures against E. coli and S. albus. 
3.4 Conclusions 
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Chapter IV 
Influence of synergism between antibiotics and silver nanoparticles on antibacterial activity: ampicillin, penicillin G and polymyxin B 
 
4.1  Introduction 
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one microorganism in a specific habitat and set of environmental conditions to disturb neighbouring microbes, either to regulate their growth or to activate their elimination.[3]  The range of bacteria or other microorganisms that is affected by a certain antibiotic is expressed as its spectrum of action. When antibiotics are effective against prokaryotes to kill or inhibit a wide array of Gram positive and Gram negative bacteria, they are known to be of broad spectrum. If effectiveness is primarily against either Gram positive or Gram negative bacteria, they are of narrow spectrum. Additionally, if effective against a single organism or disease, they are referred to as limited spectrum. A medically useful antibiotic should have as many of these characteristic as possible:[4] 
 Possess a wide spectrum of activity with the ability to destroy or inhibit many different species of pathogenic organisms 
 Nontoxic to the host and without undesirable side effects 
 Non-allergenic to the host 
 Inexpensive and easy to produce 
 Chemically-stable (long shelf life) 
 Least chance of microbial resistance 




81   
susceptible. Susceptible bacteria are killed or inhibited by an antibiotic, resulting in a selective pressure whereby antibiotic-resistant bacteria are allowed to survive and multiply. Some bacteria are naturally resistant to certain types of antibiotics, and may also become resistant in two ways: genetic mutation or by acquiring resistance from another bacterium.[6-8] Figure 4.1 illustrates how antibiotic resistance spreads in day to day life from humans and animals.  
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protein transporters localised in the cytoplasmic membrane in cells. However, the impact of efflux mechanisms on antimicrobial resistance is relatively vast. This may attribute to genetic elements encoded on chromosomes and plasmids. Antibiotics can act as inducers and regulators of some efflux pumps causing over-expression of several efflux pumps in a given bacterial species. However this can lead to a broad spectrum of resistance when shared across species.[9, 10]  
Consequently, the extensive use of antibiotics has led to a worldwide escalation of bacterial resistance and spread of many pathogens which is a serious concern for modern day medicine. High prevalence of multidrug-resistant bacteria among bacteria-based infections decreases effectiveness of current treatments and causes millions of deaths.[11, 12] Antibiotics are also commonly found in food of animals to prevent, control and treat disease, and to promote the growth of food-producing animals. The foremost problem is that bacteria and other microbes that cause infections are remarkably resilient and have developed several ways to resist antibiotics and other antimicrobial drugs. Moreover, resistance is due to increasing use and misuse of existing antibiotics in human and veterinary medicine as well as in agriculture. Other factors contributing to the development of antimicrobial resistance are:[13, 14] 
 Single mode of action of particular antibiotics 
 Evolving microorganisms themselves, escalation of emerging and re-emerging infectious diseases 
 Combination of increased pressure of antibiotic selections  
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4.1.1 Ampicillin 
 Ampicillin, commonly known as broad-spectrum aminopenicillin is a β-lactam (beta-lactam) antibiotic which belongs to the broad class of antibiotics and has been extensively used to treat bacterial infections. Since it is classified to be in the broad spectrum, ampicillin is effective against Gram negative as well as Gram positive organisms. Aminopenicillins were created by joining penicillin to an amino group or side chain. Addition of the side chains significantly changed the activity of the antibiotic drug against some bacteria.  
 
Figure 4.2- Chemical structure of ampicillin. 
4.1.2 Penicillin G 
Penicillin G, also known as benzylpenicillin is a derivative from penicillin. Penicillin G possesses a narrow spectrum of effectiveness against microorganisms, mainly against Gram positive bacteria. The structure of penicillin G is shown in Figure 4.3. 
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4.1.3 Polymyxin B 
Polymyxin B is a lipopeptide antibiotic isolated from Bacillus polymyxa. Its basic structure consists of a polycatonic peptide ring and a tripeptide side chain with a fatty acid tail as shown in Figure 4.4. This antibiotic has a narrow spectrum and is active against most Gram negative bacteria.  
 
Figure 4.4- Chemical structure of polymyxin B. 
4.2 Experimental  
4.2.1 Synthesis of Ag nanospheres 
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4.2.2 Antibacterial study 
 All antibacterial experiments were performed under aseptic conditions in a laminar flow cabinet. Before the commencement of microbiological experiments, media cultures, glassware and pipette tips were sterilised by autoclaving at 121°C for 15 minutes. Escherichia coli was chosen as Gram negative representative and Gram positive bacterium Staphylococcus albus was another candidate for antibacterial studies. Antibiotics used were ampicillin, penicillin G and polymyxin B.  
4.2.2.1 Colony forming units (CFU) assay 
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Table 4.1- Optimum concentration of antibiotics needed for further studies. 
Antibiotics E. coli culture S. albus culture 
 
Stock Solution 
Aliquot for 20% cell 
death Stock Solution 
Aliquot for 20% cell 
death Ampicillin (+, -) 1 mg / mL 50 µL  1 mg / 5 mL 10 µL  Penicillin G (+) - - 1 mg / 5 mL 2 µL  Polymyxin B (-) 0.0125 mg / mL 10 µL   - - Subsequently, each aliquot of antibiotics as determined in Table 4.1 was combined with different concentrations of Ag nanospheres such as 0.5 mM, 1 mM, 1.5 mM and 2.0 mM and were tested for their synergistic effects on both Gram positive and Gram negative bacteria via CFU assay. It may be noted that while further discussed nanoparticle characterisation aspect investigates only nanoparticles conjugated to antibiotics (through removal of free antibiotic in nanoparticle solution by centrifugation), the antibacterial tests took both free and conjugated antibiotics into account as per the above Table 4.1.  
4.3 Results and discussion 
4.3.1 UV-Visible spectral studies of antibiotics and Ag nanoparticles 
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the surface plasmon resonance (SPR) peak maxima of Ag shifted to ca. 419, 421 and 441 nm in case of AMP, PCG and PMB respectively. These shifts in Ag SPR peak maxima supports successful binding of antibiotics to the Ag nanoparticle surface.  
 
Figure 4.5- UV-Visible absorbance studies on pristine antibiotics on its own and antibiotics combined with Ag nanoparticles. 
4.3.2 TEM and DLS studies of antibiotics combined with Ag nanoparticles 
 Illustrated in Figure 4.6 are  TEM images of Ag nanoparticles combined with various antibiotics with corresponding particle size histograms. Images reveal that these particles are quasi spherical in shape with low polydispersity. The pristine tyrosine reduced Ag nanoparticles were found to be of ca. 21.8 ± 5.0 nm in diameter as shown in previous Chapter III. The average particle diameter for each nanomaterial after antibiotic exposure was calculated along with the standard deviation of ca. 22.1 ± 8.2 nm, 21.7 ± 7.7 nm and 23.4 ± 7.1 nm for Ag nanoparticles combined with ampicillin, penicillin G and polymyxin B respectively. The nanomaterials are relatively similar in sizes and 
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there were no signs of aggregation post antibiotic exposure which is consistent with UV-Vis spectroscopic observation.  
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Ag nanoparticles after exposure to antibiotics suggest a ligand exchange between tyrosine and antibiotics.  
 
Figure 4.7- DLS size distribution of (a) AgNPs+AMP (b) AgNPs+PCG and (c) AgNPs+PMB. 
4.3.3 FTIR analysis of antibiotics combined with Ag nanoparticles 
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respectively when combined with Ag nanoparticles. These shifts suggest that there is interaction between penicillin G and the metal surface through the C=C bond.[26, 28] 
 
Figure 4.8- FTIR spectral analysis of Ag nanoparticles and antibiotics.  In the spectrum for pure polymyxin B, bands at ca. 1649 cm-1 and 1539 cm-1 are attributed to the amide I and II vibrational modes.[26, 29, 30] These frequencies were slightly shifted to ca. 1647 cm-1 and 1536 cm-1 upon exposure to Ag nanoparticles. The shifts indicate the binding of polymyxin B on Ag nanoparticles. Additionally, broad O-H peaks ca. 3650 cm-1 to 2800 cm-1 are present in all cases of antibiotics and when antibiotics are combined with Ag nanoparticles. These peaks are attributed to water molecules apparent within the samples.  
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Table 4.2- Summary of functional groups in Ag nanoparticles and antibiotics combined with Ag nanoparticles. 
Wavenumber (cm-1) Bond Functional group Appearance 
AgNPs with Ampicillin 3650 - 2800 O-H stretch Hydroxyl Broad 1765 C=O stretch  Aldehyde/Ketone  Weak 1700 - 1450 C=C stretch Aromatic rings Weak 1393 C–O stretch Aromatic rings Weak 1280 C–O stretch Aromatic rings Weak 
Ampicillin 3650 - 2800 O–H stretch Hydroxyl Broad 1765 C=O stretch  Aldehyde/Ketone  Weak 1700 - 1450 C-C stretch Aromatic rings Weak 1393 C-O stretch Aromatic rings Weak 1280 C-O stretch Aromatic rings Weak 
AgNPs with Penicillin G 3356 N–H stretch  Amine Narrow and sharp 3088 - 2858 C–H stretch Alkane Broad 1773 C=O stretch Aldehyde/Ketone Medium 1604 C=O stretch Aromatic rings Medium 1499 C=C stretch Aromatic rings Medium 1311 C=C stretch Aromatic rings Medium 3356 N–H stretch  Amine Narrow and sharp 
AgNPs with Penicillin G 3088 - 2858 C–H stretch Alkane Broad 1792 C=O stretch Aldehyde/Ketone Medium 1604 C=O stretch Aromatic rings Medium 1516 C=C stretch Aromatic rings Medium 1322 C=C stretch Aromatic rings Medium 
AgNPs with Polymyxin B 3650 - 3150 O–H stretch Hydroxyl Broad 1647 N–H stretch Amide Medium 1539 N–H stretch Amide Medium 
Polymyxin B 3650 - 3150 O–H stretch Hydroxyl Broad 1649 N–H stretch Amide Medium 1536 N–H stretch Amide Medium 
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4.3.4 X-ray photoelectron spectroscopy (XPS) of antibiotics combined with 
Ag nanoparticles 
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Figure 4.9- XPS spectra of tyrosine reduced Ag nanoparticles. The antibiotic ampicillin was added to these nanoparticles and X-ray photoelectron spectroscopy was used to determine the binding of antibiotic with Ag nanoparticles to identify which functional groups of ampicillin take part in binding. Shown in Figure 4.9 are the 1s core level spectra for carbon, nitrogen and oxygen of ampicillin as well as Ag nanoparticles bound with ampicillin molecules. The C 1s spectra was fitted with three chemically distinct carbon species and their BEs were observed at 285.02, 286.55 and 288.18 eV, respectively. These three chemical states of carbon were assigned to the aromatic carbon, carbon that bound to the amine groups and carboxylic acid carbon. The spectra for ampicillin is presented in Figure 4.10. The N 1s spectrum for ampicillin shows an intense peak at 400.16 eV, which was assigned to secondary amine nitrogen group. The higher N 1s binding energy component observed at 402.11 eV represents the primary amine group and the weak component at 398.7 eV can be assigned to the nitrogen in a cyclic structure. O 1s core level spectrum shows two intense chemically different oxygen species, representing the carbonyl oxygen (532.77 eV) and carboxylate oxygen (532.13 eV). A weak O 1s component observed at 534.87 eV was assigned to the carbonyl oxygen present in the four membered ring.  
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Ag nanoparticles. All these changes clearly indicated that ampicillin bind with the Ag nanoparticles through its carboxylic acid group, by partially replacing tyrosine from the nanoparticles surface. Therefore, XPS analysis further supports DLS observations, which indicated ligand exchange between tyrosine and antibiotics. Since both tyrosine and ampicillin have carboxylic acid groups and they can bond with the nanoparticles surface, the probable mode of binding of ampicillin with Ag nanoparticles is shown in Figure 4.11.  
 
Figure 4.11- Scheme illustrating the structure of Ag nanoparticle with bound ampicillin antibiotic. Illustrated in Figure 4.12 is the XPS core level spectra of penicillin G and after its functionalisation with Ag nanoparticles. The C 1s spectra of penicillin G was deconvoluted into three chemically distinct carbon species and their BEs were observed at 285.01, 286.34 and 288.03 eV respectively. These three chemical states of carbon were assigned to the aromatic carbon, amine groups bearing carbon and carbon in the carboxylic acid functional group. The N 1s spectrum for ampicillin shows a major peak at 400.00 eV, which was assigned to the secondary amine nitrogen group. Another N 1s component fitted at 399.34 eV was assigned to the nitrogen present in the cyclic structure. O 1s core 
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level spectrum shows three chemically distinct species, representing the carbonyl oxygen (532.03 eV), carboxylate oxygen (531.14 eV) and the carbonyl oxygen present in the four membered ring (535.69 eV). 
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were shifted to 531.48 eV with clear signature of carboxylic acid group binding with Ag nanoparticles. The BE of the carbonyl group present in the four membered ring shifted from 535.69 eV to 535.99 eV, which is again due to the proximity of this functional group to the Ag nanoparticles surface owing to the binding of carboxylic acid group with the Ag nanoparticles. In the case of N 1s spectra, the BE of the nitrogen present in the four membered ring only was shifted to 399.49 eV, which is again due to the proximity of the four membered ring to the Ag nanoparticles surface. Penicillin G and ampicillin differ only in the number of amine groups (additional groups in ampicillin), therefore their mode of binding is almost similar. They both bind with the Ag nanoparticles through their carboxylic acid groups by partially replacing tyrosine molecules from the Ag nanoparticles surface. The probable mode of binding of penicillin G with the Ag nanoparticle is given in the following Figure 4.13. 
 
Figure 4.13- Scheme illustrating the structure of the Ag nanoparticle with bound penicillin G. Polymyxin B is a larger antibiotic, structurally different from penicillin G and ampicillin (Figure 4.14). The C 1s spectra of polymyxin B was deconvoluted into three chemically distinct carbon species and their BEs were observed at 284.98, 286.38 and 
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288.07 eV respectively. These three chemical states of carbon were assigned to the aromatic carbon, amine/hydroxyl groups bearing carbon and carbon in the carbonyl group of the amide functional group. The N 1s spectrum for polymyxin B shows a major peak at 400.01 eV, which was assigned to the amide nitrogen groups.  Additionally two N 1s components fitted at 401.40 and 401.94 eV were assigned to the primary amine group nitrogen present in the decapeptide and tail of the polymyxin B respectively. O 1s core level spectrum was deconvoluted into two chemically distinct O components, representing the carbonyl oxygen (531.41 eV) present in the amide groups and alcohol functional groups (533.21 eV).  
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Ag nanoparticles by replacing the tyrosine molecules from its surface. This minimal replacement of tyrosine molecules bound onto Ag nanoparticle surface is further reflected from DLS analysis. DLS revealed that while ampicillin and penicillin G caused significant reduction in hydrodynamic diameters, only limited reduction in the DLS size of Ag nanoparticles was observed during polymyxin B functionalisation. Moreover, significant changes are observed in the O 1s binding energies after addition of polymyxin B to Ag nanoparticles. In particular, the BE component corresponding to the hydroxyl/alcohol groups diminished its intensity. This indicates that polymyxin B can bind through the alcohol functional groups present in the long chain attached to the decapeptide. This would be beneficial as the antibiotic component is undisturbed and the probable mode of binding is given below in Figure 4.15. 
 
Figure 4.15- Scheme illustrating the structure of the Ag nanoparticle with bound polymyxin B. Shown in Figure 4.16 are the Ag 3d5/2 and 3d3/2 spin-orbit components of the Ag scan. The tyrosine reduced Ag nanoparticles exhibit two chemically distinct peaks in the Ag 3d5/2 region at 367.88 and 369.18 eV which have been previously assigned to silver 
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metal and unreduced silver cations, respectively.[31] The presence of silver cations in this spectrum suggests that unreduced silver ions remain bound to the nanoparticle surface. Each of the Ag nanoparticles with bound antibiotics display peaks at ca. 368.3 and 374.3 eV representing Ag0, higher than the initial silver binding energy. This is a clear indication that the chemical environment of Ag nanoparticles has been changed as a result of antibiotic binding.  
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4.3.5 Antibacterial assays of antibiotics and Ag nanoparticles 
 Colony count method was used to investigate the synergistic effects of Ag nanoparticles combined with antibiotics against Gram positive and Gram negative bacteria. Since all antibiotic concentrations were set at a constant cell death of 20%, to achieve synergism, the percentage cell death of antibiotics combined with Ag nanoparticles needs to be greater than the sum of the individual cell death (CD) percentage of antibiotics and Ag nanoparticles (i.e., CD% AgNPs/Antibiotics combined > CD% antibiotics + CD% AgNPs). 
4.3.5.1 Synergistic effects of ampicillin combined with Ag nanoparticles 
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Conversely, in the case of Ag nanoparticles combined with ampicillin against 
S. albus as shown in Figure 4.17B, at the lowest concentration of 0.1 mM, the synergistic enhancement achieved was ca. 49%. It was then decreased to ca. 17% synergism at 0.2 mM of silver concentration. As the concentrations increased to 0.5 mM and 1.0 mM, limited synergistic effects were apparent, at only 3-4% enhancement. Table 4.3 displays a summary of the synergistic effects between the studies of E. coli and S. albus.  
 
 
Figure 4.17- Synergistic effects of Ag nanoparticles and ampicillin against (A) E. coli and (B) S. albus. 
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4.3.5.2 Synergistic effects of penicillin G or polymyxin B combined with 
Ag nanoparticles 
Synergistic effects of penicillin G was tested only against Gram positive bacteria 
S. albus as it is of narrow spectrum antibiotic (Figure 4.18). All concentrations demonstrated synergistic effects, with the lowest concentration of 0.1 mM exhibiting the highest outcome. At 0.1 mM of silver, the individual sum of percentage cell death of penicillin G and Ag nanoparticles demonstrated ca. 37%, and the combined effect displayed ca. 69% cell death which suggests a significant synergistic enhancement of ca. 87%.  As the concentration of silver increases, the synergistic effects decrease to 42% (for 0.2 mM Ag), 14% (0.5 mM Ag) and 10% (1.0 mM Ag). At higher concentrations, Ag nanoparticles itself exhibits significant antibacterial effects therefore at those concentrations, the synergism between antibiotics and Ag nanoparticles becomes less effective compared to lower concentrations.  
 
Figure 4.18- Synergistic effects of Ag nanoparticles and penicillin G against S. albus. 
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Similar outcomes were achieved in the case of Ag nanoparticles combined with Gram negative specific polymyxin B where synergistic effects profile was tested against Gram negative bacteria E. coli. Again, as illustrated in Figure 4.19, at lower concentrations of silver, synergism is clearly evident. When 0.1 mM silver was used, the individual sum of percentage cell death of polymyxin B and Ag nanoparticles achieved was ca. 54% compared to 100% cell death when Ag nanoparticles and polymyxin B were combined. This produces an additional effect of ca. 46% and a high synergistic enhancement of ca. 85%. The percentage cell death of Ag nanoparticles combined with antibiotics is ca. 100% across all four concentrations.  
 
Figure 4.19- Synergistic effects of Ag nanoparticles and polymyxin B against E. coli. Similar to all other antibiotics, as the silver concentration increases, the synergistic effect appears to decrease. This is shown clearly in Table 4.3 which summarises all the synergistic effects of each antibiotic combination. It can be demonstrated that the lower the silver concentration, the better the synergistic enhancements across all antibiotic combinations. The highest synergism was demonstrated in 0.5 mM for polymyxin B against E. coli at ca. 85% and for penicillin G 
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against S. albus at ca. 87%, whereas, the similar concentration of Ag nanoparticles in case of broad spectrum ampicillin caused only 43% and 49% synergistic enhancements in case of E. coli and S. albus, respectively.  
Table 4.3- Summary of synergistic effects of each antibiotic combination. 
*  [𝐶−(𝐴+𝐵)](𝐴+𝐵) × 100    
























Ampicillin against E. coli 0.1 20 34 54 77 23 43 0.2 20 40 60 86 26 43 0.5 20 52 72 87 15 21 1.0 20 59 79 93 14 18 
Ampicillin against S. albus 0.1 20 17 37 55 18 49 0.2 20 32 52 61 9 17 0.5 20 51 71 73 2 3 1.0 20 57 77 80 3 4 
Penicillin G against S. albus 0.1 20 17 37 69 32 87 0.2 20 32 52 74 22 42 0.5 20 51 71 81 10 14 1.0 20 57 77 85 8 10 
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4.3.6 SEM of bacteria cells after treatment of Ag nanoparticles and 
antibiotics 
 Physical composition of bacterial cell is essential for its survival and to overcome environmental changes and stress. Hence, the morphological changes that occur in the bacterial cells after exposure to Ag nanoparticles, antibiotics, and Ag nanoparticles combined with antibiotics are illustrated in Figure 4.20-4.23.   As mentioned previously, ampicillin is a broad spectrum antibiotic which targets Gram negative and Gram positive bacteria. In the study of ampicillin, SEM images of bacteria cells without treatment and those treated with Ag nanoparticles and ampicillin are demonstrated below in Figure 4.20.  
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Upon exposure of Ag nanoparticles combined with ampicillin (Figure 4.20C), SEM images illustrated distinct morphological changes in E. coli. This change is indicative of significant damage to bacterial cell integrity. The combined effect of Ag nanoparticles and ampicillin on E. coli is evident where further damage of cells is seen compared to ampicillin on its own. Furthermore, the bacterial cells are completely fragmented and the dissolving of the bacterial cell walls is evident. These disintegrated cells provide distinct evidence that there are distinct changes in the morphology of the cells.  Figure 4.21 displays SEM images of S. albus bacterial cells with and without the treatment of ampicillin and combined Ag nanoparticles and ampicillin. The control image of S. albus without exposure (Figure 4.21A) is arranged in grape-like clusters. Upon treatment of ampicillin, cells become fused together as illustrated in Figure 4.21B and this provides evidence of some interaction between ampicillin and bacterial cells.  The combined effects of Ag nanoparticles and ampicillin exposed to S. albus are illustrated in Figure 4.21C. As evident in the image, the cell wall components appeared to be exfoliating and a change in morphology is apparent. 
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surfaces were peeling (Figure 4.22B). When Ag nanoparticles are combined with penicillin G (Figure 4.22C), S. albus cells are dissolved and cellular components appeared to be disintegrated. After treatments, the cell wall components are disorganised and scattered from the original ordered close packed smooth arrangement.  
Figure 4.22- SEM images of S. albus (A) untreated, (B) treatment with penicillin G and (C) treatment with Ag nanoparticles combined with penicillin G. (Scale bars corresponds to 5 µm)  Illustrated in Figure 4.23, is the profile for polymyxin B (narrow spectrum) against 
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reduction in the initial cell thickness as well as roughening of the cell which caused the disruption of the cell wall and membrane.  
Figure 4.23- SEM images of E. coli (A) untreated, (B) treatment with polymyxin B and (C) treatment with Ag nanoparticles combined with polymyxin B. (Scale bars corresponds to 5 µm)  From antibacterial studies and SEM imaging of bacterial cells, it is clear that Ag nanoparticles combined with antibiotics has synergistic effects which cause significant irreversible bacterial cell damage and ultimately cell death by disruption of the cell wall and membrane when compared with antibiotics on its own.  
4.3.7 Mechanism of action 
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inhibited respiration.[38] Since all of the antibiotics employed in this study act on bacterial cell wall, it is not surprising that in the presence of antibiotics, nanoparticle uptake may be significantly enhanced. This is most likely the dominant reason for large synergistic enhancement observed when nanoparticles are jointly used with antibiotics.  
4.4 Conclusions 
 Ag nanomaterials are known for their biological applications due to their high surface area to volume ratio. Ag nanoparticles have been employed as potent antibacterial agents to overcome resistance. Of many different approaches to overcome antimicrobial resistance, using Ag nanoparticles as antibiotics carriers seems to hold highest promise. Hence, this chapter has demonstrated that antibiotics bound onto Ag nanoparticles as well as those present freely around nanoparticles revealed noteworthy influence on antibacterial activities.   Additionally, traditional antibiotics with various spectrums were employed as functional fragments to influence antibacterial potential on the surface of Ag nanoparticles.   Furthermore, this chapter provides strong evidence that antibiotic combined Ag nanoparticles provide synergistic effects and employ a physical mode of action against bacterial cells causing cell wall cleavage and cell lysis. Although Ag nanoparticles combined with antibiotics may not replace antibiotics, but they may become valuable antibiotic complements by preventing the development of resistance. 
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Chapter V 
Influence of surface corona of silver nanoparticles on antibacterial activity: tyrosine, curcumin and epigallocatechin gallate  
5.1  Introduction  
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Tyrosine or 4-hydroxyphenylalanine is an essential aromatic amino acid that is derived from phenylalanine by hydroxylation in the para position. This amino acid acts as one of the building blocks of protein. Tyrosine can be synthesised in the body from phenylalanine, found in high protein packed produces, in plants and most microorganisms. The structure of tyrosine is shown below in Figure 5.1 consisting of one phenolic group.  
 
Figure 5.1- Chemical structure of tyrosine.   The polyphenol curcumin is the active ingredient found in the traditional herbal remedy and dietary spice turmeric, also known as Curcuma longa. Turmeric is a member of the Curcuma botanical group, which is part of the ginger family of herbs. Grounded turmeric produces a vibrant yellow-orange colour from a naturally occurring pigment in the Curcuma longa tuber; this pigment is the source of curcumin. The warm yellow spice, derived from the rhizome of the plant (Figure 5.2), has a long history of use in traditional Chinese and Indian medicines, asian cooking, cosmetics and fabric dying for more than 2000 years.[28-31] 
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The use of curcumin as an ancient remedy continues today in India where a bandage of turmeric paste is used to treat infections, wound dressings, burns, acne and different skin diseases.[31] In food and manufacturing, curcumin is presently used in perfumes as a naturally yellow colouring agent, as well as a food additive to flavour various types of curries and mustards.[32, 33] Recent emphasis on employing the use of natural and complementary medicines in Western medicine has diverted the attention of the scientific community to this ancient remedy. Researchers have revealed that curcumin possesses an extensive range of beneficial properties, including antimicrobial,[34-36] anti-inflammatory,[37-39] antioxidant,[40-42] anti-carcinogenic, chemopreventive and chemotherapeutic activity.[43-46] Curcumin is a free radical scavenger and hydrogen donor which exhibits antioxidant activity. Sharma et al. observed that the phenolic hydroxyl groups are essential for antioxidant activity.[47] Illustrated in Figure 5.3 is the structure of curcumin, consisting of two phenolic groups.  
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preventative properties of EGCG have also received recognition as various mechanisms for the preventive effect were suggested. These include antioxidant activity, direct binding to specific carcinogens and induction of apoptosis.[61, 62] As shown in Figure 5.4 is the structure of EGCG which consists of eight phenolic groups.  
 
Figure 5.4- Chemical structure of EGCG.    Polyphenols possess strong antioxidant properties and has been documented comprehensively.[63-67] The typical mode of action for polyphenols is mainly due to their ability to donate hydrogen atoms (5.1) or electrons (5.2).[63, 68, 69] 
𝑅⦁ + 𝐴𝑟𝑂𝐻 → 𝑅𝐻 + 𝐴𝑟𝑂⦁ (5.1) 
𝑅⦁ + 𝐴𝑟𝑂𝐻 → 𝑅− + 𝐴𝑟𝑂𝐻⦁+  (5.2)  In the hydrogen-atom transfer (HAT) mechanism in Equation 5.1, the free radical (R⦁) removes a hydrogen atom from the phenolic antioxidant (ArOH) and becomes a free radical (ArO⦁) itself. This transfer is through homolytic rupture of the O-H bond.  The formation and stability of ArO⦁ is highly dependent upon the structural features of the ArOH compound. The most crucial determining factors are: 
 Presence, number and relative positions of additional phenolic hydroxyl groups, 
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 Conformation dependent possibility of allowing electronic delocalisation throughout the largest part of the molecule All these factors affect the bond dissociation energy (BDE) of the phenolic O-H bond, where the weaker the O-H bond, the easier the H-atom transfer will be.   The second mechanism is the single-electron transfer (SET) displayed in Equation 5.2 from ArOH to a free radical R⦁ with formation of a stable radical cation ArOH⦁+. The ionisation potential (IP) of ArOH is another essential physicochemical parameter for evaluating the antioxidant efficacy of plant polyphenols where the lower the IP, the easier the electron abstraction.   The BDE and IP of polyphenols provide interesting information about the efficiency and the activity of the phenolic antioxidants.  The following Table 5.1 provides the list of BDEs and IPs for the phenolic compounds used in this chapter from the literature. Thus, it is expected that the antibacterial activity of Ag nanoparticles may be improved by using phytochemicals such as curcumin and EGCG as reducing and capping agents. 
Table 5.1- BDE and IP of phenolic compounds found in literature. 
Phenolic Compound BDE (kJ/mol) IP (eV) Tyrosine 350[70] 8.0[71] Curcumin 348[72] 7.5[72] EGCG 294[73] 7.1[74] 
5.2  Experimental 
5.2.1 Synthesis of tyrosine reduced Ag nanoparticles 
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5.2.2 Synthesis of curcumin reduced Ag nanoparticles 
 In a typical experiment, 10 mL of 10-3 M aqueous silver sulphate (containing 2 × 10-3 M equivalent of Ag+ ions) was prepared and added to 20 mL of 10-3 M aqueous solution of curcumin. This solution was then diluted to 100 mL with Milli-Q water. To this solution, 1 mL of 10-1 M KOH was added and was allowed to boil. Within 15 min, the final colourless solution changed into yellow in colour which indicates the formation of nanoparticles. Curcumin reduced Ag nanoparticles were also synthesised with a mole ratio of 1:2 (Curcumin: Ag), wherein while concentration of Ag+ ions were kept constant, the amount of curcumin was reduced to 50%.  
5.2.3 Synthesis of EGCG reduced Ag nanoparticles 
 In a typical experiment, 20 mL of 10-3 M aqueous silver sulphate was prepared and added to 10 ml of 10-3 M aqueous solution of EGCG. This solution was then diluted to 100 mL with Milli-Q water. To this solution, 1 mL of 10-1 M KOH was added and was allowed to boil. Within 15 min, the final colourless solution changed into green/yellow in colour which indicates the formation of nanoparticles. EGCG reduced Ag nanoparticles were also synthesised with mole ratio of 1:3 (EGCG: Ag) and 1:8 (EGCG: Ag), wherein with a constant amount of Ag+ ions, the amount of EGCG was reduced to one-third and one-eighth respectively. 
5.2.4 Processing of Ag nanoparticles by concentration and dialysis 
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strongly capped with their precursors. The solutions were stable under standard laboratory conditions at room temperature and used for further characterisation and biological applications.    
5.2.5 Quantification of Ag nanoparticles by atomic absorption 
spectroscopy (AAS) 
 Before the utilisation of further applications, AAS was used to determine the concentration of silver within each sample.  Ag nanoparticles were initially dissolved in nitric acid and calibration standards were prepared using standard silver nitrate solution. Based on silver standards, a calibration graph was created and concentrations of silver within each sample were determined. Samples were then diluted to desired concentration for use.   
5.2.6 Antibacterial applications 
 All antibacterial experiments were performed under aseptic conditions in a laminar flow cabinet. Before the commencement of microbiological experiments, media cultures, glassware and pipette tips were sterilised by autoclaving at 121°C for 15 minutes. Gram negative Escherichia coli (E. coli) and Gram positive bacterium 
Staphylococcus albus (S. albus) were used as microorganisms for antibacterial applications.  
5.2.6.1 Colony forming units (CFU) assay 
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100 µL of this was then plated on agar plates. These plates were then incubated for 24 hrs at 37°C and the numbers of colonies were counted. Colonies formed correspond to the number of viable bacteria in each suspension at the time of aliquot withdrawal.  
5.3 Results and discussion 
5.3.1 UV-Visible spectral studies of functionalised Ag nanoparticles 
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Figure 5.5- UV-Visible spectra of tyrosine, curcumin and EGCG reduced Ag nanoparticles in different mole ratios.   
   
Figure 5.6- UV-Visible spectra of functionalised Ag nanoparticles separated for clarity.    Similarly, at equimolar (1:1) concentration of EGCG reduced Ag nanoparticles, SPR bands are observed at ca. 406 nm. As the amount of EGCG is decreased, the peak at ca. 406 nm shifted to 404 nm for (1 EGCG: 3 Ag) and (1 EGCG: 8 Ag) with a decrease of intensity. Again, the intensities of the ratios decrease as less EGCG is apparent within the sample, suggesting the lack of enough reducing agent to allow complete reduction of Ag+ ions. 
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5.3.2 Silver reducing capabilities of phenolic compounds via AAS 
 Dialysed solutions were analysed by AAS to determine the concentration of silver after functionalised nanoparticle reduction. During the synthesis of each sample, the amount of precursor capping and reducing agent i.e. tyrosine, curcumin and EGCG, was decreased according to their phenolic group present within their structure. For example, in the case of amino acid tyrosine, only one active phenolic group is present, therefore an equimolar ratio of 1:1 (Tyr:Ag) was studied. As for the structure of curcumin, two phenolic groups are present hence ratios of 1:1 and 1:2 were studied. EGCG on the other hand consists of multiple phenolic groups, leading ratios of 1:1, 1:3 and 1:8 to be synthesised. During the synthesis, since 0.1 mM Ag2SO4 was employed, it corresponds to 0.2 mM Ag+ ions that remained constant for all six nanoparticle solutions. Illustrated below in Table 5.2, depicts the concentrations of silver present before and after synthesis according to AAS analysis.  
Table 5.2- Concentrations of silver and phenolic compounds and their reducing capabilities. 
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Although the ratios of phenolic compounds to silver were decreased, the reducing capabilities within each sample did not significantly differ. This suggests that more than one phenolic group present in curcumin and EGCG structure can simultaneously participate in reduction of Ag+ ions.  
5.3.3 TEM and DLS measurements of functionalised Ag nanoparticles 
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and 1:8 mole ratios respectively. According to Ejima et al., it was found that the increase in salt concentration affects the morphology of nanomaterials.[77] In that study, with an increasing metal ion concentration with respect to a polyphenol as a reducing agent, larger film assembly and increase of roughness was observed. Similarly, in this study while overall Ag+ ion remain constant, the Ag2SO4 concentration has been artificially increased with respect to relative amount of EGCG present.  
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Alternatively, size distribution of the functionalised Ag nanoparticles was also investigated via dynamic light scattering (DLS). DLS provides information on the hydrodynamic radii of nanoparticles in solution by measuring the time sale of light intensity fluctuations. DLS measurements in Figure 5.8 provided the trend in change of the average hydrodynamic radius for each mole ratio. The average hydrodynamic radius for tyrosine reduced Ag nanoparticles was 41.4 nm (equivalent to hydrodynamic diameter 82.8 nm). 
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131.4 nm) for equimolar ratio, 75.6 nm (equivalent to hydrodynamic diameter 151.2 nm) for 1:3 mole ratio and 75.6 nm (equivalent to hydrodynamic diameter 151.2nm) for 1:8 mole ratio. 
5.3.4 X-ray diffraction (XRD) studies of functionalised Ag nanoparticles 
 Silver crystallises in a cubic close packed structure. The unit cell for this structure is cubic consisting of the same length and all faces are perpendicular to each other.  Silver atoms are present at each corner as well as in the centre of each face of the unit cell. This unit cell is also known as a face-centered cubic (FCC) unit cell. Structural information of functionalised Ag nanoparticles were attained via XRD using a general area detector diffraction system (GADDS) as shown in Figure 5.9. 
 
Figure 5.9- XRD patterns of functionalised Ag nanoparticles.  Diffraction patterns of functionalised Ag nanoparticles confirmed the crystalline structure of silver nanoparticles and are normalised to the (111) peak. All peaks in the XRD pattern can be readily indexed to a face-centered cubic structure of silver. Curcumin 
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reduced Ag nanoparticles in all mole ratios displayed characteristic (111), (200) and (220) peaks which represents the FCC silver plane in Bragg’s Law. In the case of EGCG reduced Ag nanoparticles, the same (111), (200) and (220) peaks of silver are shown. Additionally, an extra peak at (311) plane of silver FCC is apparent across all mole ratios, however intensity decreases as mole ratios rises to 1:8. The XRD pattern of tyrosine reduced Ag nanoparticles is provided in Chapter III.  
5.3.5 FTIR analysis to understand surface corona of functionalised 
Ag nanoparticles 
 Tyrosine reduced Ag nanoparticle FTIR can be found in Chapter III.  
5.3.5.1 FTIR analysis of curcumin-reduced Ag nanoparticles 
The molecule of curcumin as shown in Figure 5.10, have an alternating conjugated symmetrical structure with single (-C-C-) and double (-C=C-) bonds. There are two benzene rings, two methoxy and predominantly two hydroxyl functional groups. Curcumin can also exist in two tautomeric forms in the central part of the molecule; keto with two C=O groups, and a C=O and C-OH group for enol form.  
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intermolecular hydrogen bonding and this can be seen in Figure 5.11, with a weak sharp peak at ca. 3509 cm-1. Towards the middle region, a sharp peak at ca. 1627 cm-1 has a predominately mixed C=C and C=O character of the benzene ring. The observed shoulder peak at ca. 1602 cm-1 is attributed to the symmetric aromatic ring stretching vibrations C=Cring. The medium intensity peak at ca. 1506 cm-1 is assigned to the C=O. Most bands in the frequency region 1400 cm-1 to 1490 cm-1 are highly mixed with one clear band at ca. 1428 cm-1. This band corresponds to deformation vibrations of the two methyl groups. In-plane deformation vibrations of CCH of phenyl rings and skeletal in-plane formations are observed at ca. 1274 cm-1 and ca. 1182 cm-1 respectively.  In the range of 1320 cm-1 to 1200 cm-1, the observed bands at 1315 cm-1 and 1204 cm-1 are attributed to C-O and  C=C-H of interring chain respectively.  In this fragment the vibrations of the phenyl group are intensely mixed with skeletal groups. Therefore a prominent peak at ca. 1152 cm-1 corresponds to C-O-C vibration. The band at ca. 1024 cm-1 is attributed to the C-H out of plane vibration of the aromatic ring.  
 
Figure 5.11- FTIR spectra of pure curcumin and curcumin reduced Ag nanoparticles at various mole ratios.  
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Table 5.3- Summary of functional groups in curcumin and curcumin reduced Ag nanoparticles. 
5.3.5.2 FTIR analysis of EGCG-reduced Ag nanoparticles 
FTIR analysis of EGCG and EGCG reduced Ag nanoparticles were carried out to understand how the functional groups interact as well as for providing information on the surface chemistry of Ag nanoparticles. Illustrated in Figure 5.12 is the FTIR spectra of EGCG and EGCG reduced Ag nanoparticles. In regards to the EGCG spectrum, a weak hydroxyl peak at ca. 3359 cm-1 is observed. This is due to the vibration of the OH stretch of phenolic hydroxyl group.[79, 80] EGCG demonstrating a sharp absorption band at ca. 1691 cm-1 is assigned to C=O of the ester functional group. A peak representing a C-O 
Wavenumber (cm-1) Bond Functional group Appearance 
Curcumin 3509 O-H stretch Hydroxyl Weak 1627 C=O stretch Aromatic  Sharp 1602 C=Cringstretch Aromatic  Weak 1506 C=O Ketone Medium 1428 C-H  Alkane Medium 1315 C-O Ether Weak 1274 CCH Phenyl Medium 1204 C=C-H Alkene Narrow 1182 CCH Phenyl Weak 1152 C-O-C  Ether Medium 1024 C-H Aromatic Medium 
Curc-AgNPs 1:1 3430 O-H stretch Hydroxyl Broad 1514 C=O Ketone Weak 1272 CCH Phenyl Broad 1130 C-O-C Ether Weak 1034 C-H Aromatic Medium 
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bond can be found at ca. 1343 cm-1. Sharp aromatic ring stretching vibrations can be observed at ca. 1615 cm-1, 1527 cm-1 and 1447 cm-1.  Similarly, an aromatic alcohol C-O with a sharp band is evident at ca. 1292 cm-1. Furthermore, a sharp phenol C-O peak at ca. 1217 cm-1 and alcohol bands at ca. 1144 cm-1 and 1095 cm-1 are present.  
 
Figure 5.12- FTIR spectra of EGCG and EGCG reduced Ag nanoparticles.  Upon utilisation of EGCG in the synthesis for the formation Ag nanoparticles, numerous bands were shifted from the original EGCG spectrum. Evidence of the broadening of the hydroxyl peaks are related to the intermolecular H-bonds and O-H stretching modes in EGCG-AgNPs mole ratios of 1:1, 1:3 and 1:8 with peaks at ca. 3426 cm-1 and 3446 cm-1.[81] The assignment of the ester functional C=O peak was also shifted in all mole ratios with a weaker intensity. For EGCG-AgNPs 1:1 the peak shifted to ca. 1702 cm-1, EGCG-AgNPs 1:3 shifted to ca. 1708 cm-1 and EGCG-AgNPs 1:8 shifted to ca. 1704 cm-1.  
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Aromatic C=C band broadening and shifting is evidence in all mole ratios at ca. 1606 cm-1 (EGCG-AgNPs 1:1), 1630cm-1 (EGCG-AgNPs 1:3) and 1622 cm-1 (EGCG-AgNPs 1:8). Similarly, the same trend occurs for the alcohol functional group C-O in EGCG-AgNPs 1:3 and EGCG-AgNPs 1:8 with shifts at ca. 1120 cm-1 and ca. 1118 cm-1 respectively.  Since AgSO4 was utilised in the synthesis, sulphate SO4 peaks can be observed in all mole ratio spectral data post synthesis. These peaks occurred at ca. 1384 cm-1 (EGCG-AgNPs 1:1), 1392 cm-1 (EGCG-AgNPs 1:3) and 1390 cm-1 (EGCG-AgNPs 1:8). The structure of EGCG (Figure 5.13) and a summary of the various vibrational bands and functional groups present for EGCG and EGCG reduced Ag nanoparticles are provided in Table 5.4.   
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Table 5.4- Summary of functional groups in EGCG and EGCG reduced Ag nanoparticles.  
 
  
Wavenumber (cm-1) Bond Functional group Appearance 
EGCG 3359 O-H stretch Hydroxyl Weak 1691 C=O  Ester Sharp 1615 C=C Aromatic Sharp 1527 C=C  Aromatic Sharp 1447 C=C Aromatic  Sharp 1343 C-O Ester Sharp 1292 C-O Aromatic alcohol Sharp 1217 C-O Phenol Sharp 1144 C-O Alcohol Sharp 1095 C-O Alcohol Sharp 
EGCG-AgNPs 1:1 3426 O-H stretch Hydroxyl Broad 1702 C=O Ester Medium 1606 C=C Aromatic Strong 1384 SO4 Sulphate Weak 
EGCG-AgNPs 1:3 3446 O-H stretch Hydroxyl Broad 1708 C=O Ester Medium 1630 C=C Aromatic Broad 1392 SO4 Sulphate Weak 1120 C-O Alcohol Weak 
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5.3.6 Antibacterial assays of functionalised Ag nanoparticles 
5.3.6.1 Colony count studies for equimolar ratios of functionalised 
Ag nanoparticles. 
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significant increase in cell death at the higher end of the concentration range of 0.5 mM and 1.0 mM with ca. 79% and 94% respectively.  
 
 
Figure 5.14- CFU expressed in percentage cell death of (A) functionalised Ag nanoparticles against Gram negative E. coli and (B) functionalised Ag nanoparticles against Gram positive S. albus.   
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Overall, in regards to equimolar ratios, tyrosine reduced Ag nanoparticles displayed the least activity compared to other phenolic compounds both in the case of 
E. coli and S. albus. However, the comparative antibacterial profiles of curcumin and EGCG reduced Ag nanoparticles were different in case of E. coli and S. albus. In case of E. coli, both curcumin and EGCG reduced Ag nanoparticles showed equivalent activity while in case of S. albus, EGCG-AgNPs showed significantly higher activity than Curc-AgNPs. The relative activity profiles of different nanoparticles are in line with the dissociation energies and ionization potentials for each phenolic compound from the literature.[70-74] In general, and particularly at lower Ag concentrations, functionalised Ag nanoparticles are shown to be relatively more effective against Gram negative bacteria E. coli  over Gram positive S. albus. However, at the higher silver concentrations of 0.5 mM and 1.0 mM, EGCG reduced Ag nanoparticles produces a higher percentage cell death in the case of Gram positive S. albus. 
5.3.6.2 Colony count studies for varied mole ratios of curcumin 
reduced Ag nanoparticles. 
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percentage cell death between the ratios of 1:1 and 1:2 are ca. 20%. The difference in cell death increases at 0.5 mM to ca. 25%. Thereafter, at the highest concentration of 1.0 mM, the variance of cell death between the two ratios is minute, ca. 5%. 
 
 
Figure 5.15- CFU expressed in percentage cell death of (A) curcumin reduced Ag nanoparticles against Gram negative E. coli and (B) curcumin reduced Ag nanoparticles against Gram positive S. albus. 














Treatments (Ag concentration - mM)
 Curcumin-AgNPs 1:1
 Curcumin-AgNPs 1:2
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Moreover, the antibacterial profile for Gram positive bacteria S. albus displays similar trends as E. coli with the increase of cell death as the silver concentration rises as shown in Figure 5.15B. Likewise, curcumin reduced Ag nanoparticles at mole ratio of 1:2 (less curcumin) demonstrated the higher inhibitory effects. The difference in percentage cell death for the Gram positive S. albus is greater than that observed for E. coli. Starting at the lowest concentration of 0.1 mM, the difference is ca. 35% followed by ca. 34% at 0.2 mM concentration. The percentage cell death for mid-range of 0.5 mM concentration was at ca. 26%, relatively similar to E. coli. At the highest concentration of 1.0 mM, the deviation of cell death was ca. 17% compared to merely ca. 5% in the E. coli study.   Interestingly, it can be observed that with less curcumin functionalised onto the surface of silver, the antibacterial activity gets enhanced. This suggests that when less curcumin is used as a capping agent, the corona layer is thinner and allows the facile nanoparticle oxidation to interact with bacteria cells.  
5.3.6.3 Colony count studies for varied mole ratios of EGCG reduced 
Ag nanoparticles. 
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the lowest silver concentration of 0.1 mM, equimolar EGCG reduced Ag nanoparticles exhibited a percentage cell death of ca.  49% compared to the 1:3 and 1:8 ratios which possessed an equal cell death at ca. 67%.  At a silver concentration of 0.2 mM, the cell death of EGCG reduced Ag nanoparticles 1:3 remained the same at ca. 67% whereas equimolar and 1:8 mole ratios increased in percentage cell death at ca. 54% and 87% respectively. Similar increase of percentage cell death is apparent at 0.5 mM concentration, with ca. 61%, 71% and 93% for EGCG reduced Ag nanoparticles at equimolar, 1:3 and 1:8 mole ratios.  At the highest silver concentration of 1.0 mM, all mole ratios of EGCG reduced Ag nanoparticles possessed comparable trends with minor percentage differences in cell death.    In the case of Gram positive S. albus (Figure 5.16B), equimolar EGCG reduced Ag nanoparticles once again exhibited the least inhibitory effect across all silver concentrations. It can also be noted that at the lower end of the range of 0.1 mM and 0.2 mM, the percentage cell death is only ca. 40% and 43% respectively, which is lower than that of the E. coli study. However, this behaviour transitioned to a higher percentage of cell death as the silver concentrations increased across all mole ratios of EGCG reduced Ag nanoparticles. This observation may suggest that at higher concentrations of silver, EGCG reduced Ag nanoparticles are significantly more active against Gram positive 
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oxidation and interaction of Ag nanoparticles with bacterium. This interaction eventually leads to cell death due to multimode action of Ag nanoparticles.[82, 83] 
 
 
Figure 5.16- CFU expressed in percentage cell death of (A) EGCG reduced Ag nanoparticles against Gram negative E. coli and (B) EGCG reduced Ag nanoparticles against Gram positive S. albus.    
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5.3.7 Morphology studies of bacteria cells after the treatment of 
functionalised Ag nanoparticles 
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their original intact arrangement. This observation can confirm that curcumin reduced Ag nanoparticles (at mole ratios of 1:1 and 1:2) have considerable impact on E. coli bacterial cell morphology. Consequently, this reveals that in the case of Gram negative bacteria 
E. coli, curcumin reduced Ag nanoparticles demonstrates significant effects on membrane integrity.  
Figure 5.17- SEM micrographs of E. coli cells (A) untreated, and after treatment with (B) Curc- AgNPs (1:1) and (C) Curc-AgNPs (1:2) Scale bars 5 µm and insert scale bars 1 µm.   Illustrated in Figure 5.18 is the morphology of S. albus before and after treatment of curcumin reduced Ag nanoparticles. Untreated cells in Figure 5.18 are spherical in shape and the bacterial cluster resembles a grape-like structure. The cells possess a slightly rough surface, completely intact and undamaged in its original form. However when the cells are exposed to curcumin reduced Ag nanoparticles, there are selected fragments on the cell surface which indicates damage to the cell. The cell clusters are smoother in appearance and forms an irregular shape rather than spheres. 
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Furthermore, it is evident that as the mole ratios of curcumin reduced Ag nanoparticles are increased, the greater the cell destruction is observed. Comparing the two ratios of 1:1 and 1:2, there is a significant destruction of the bacteria cell in curcumin reduced Ag nanoparticles 1:2 (Figure 5.18A). The cell wall appears to be dissolving and completely disorganised. These micrographs confirm that curcumin reduced Ag nanoparticles also exhibits cell wall integrity effects on Gram positive bacteria, though to a lesser extent.  In correlation to the antibacterial colony count studies, EGCG reduced Ag nanoparticles displayed greater impact on E. coli cell morphology to all ratios. It is evident from the SEM images shown in Figure 5.19 that upon treatment of EGCG reduced Ag nanoparticles, the once typically rod-shaped E. coli cells were ruptured and pitting is formed within the cell wall. As the mole ratios increased to 1:8, severe pitting and greater damage is observed. Breakdown of the cell wall is also evident where cells are fractured across all mole ratios. The greatest impact on the cell morphology is achieved by EGCG reduced Ag nanoparticles at 1:8 mole ratio (Figure 5.19C). By these observations, in the case of Gram negative bacteria E. coli, EGCG reduced Ag nanoparticles demonstrate the greatest effects of membrane integrity.  
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Alternatively when EGCG reduced Ag nanoparticles are exposed to Gram positive 
S. albus, morphological changes in contrast to untreated cells are observed (Figure 5.20). The SEM images displayed signs of rupture of the cell wall and slight alteration of the bacterial shape compared to the control in Figure 5.20A. Furthermore, EGCG reduced Ag nanoparticles displayed the greatest activity in the case of S. albus compared to all functionalised Ag nanoparticles. The treated cells appear to be exfoliating and damage to membranes is recognised by the formation of pits around the cell wall. 
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or reactive oxygen species (ROS) by metal nanoparticles markedly than thin peptidoglycan layer of Gram negative bacteria as larger amounts of damage are required to impact the cell wall. 
5.4 Conclusions 
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both Gram negative and Gram positive bacteria. However, when comparing the activity between curcumin and EGCG reduced Ag nanoparticles individually in their own ratio formation, the study has shown that as the mole ratio increases with less capping of the phytochemicals, the higher the activity is demonstrated. Thus, from this study it can be concluded that a number of phenolic groups present in phytochemicals can be used to synthesise Ag nanoparticles, and also enhance antibacterial activity even at low concentrations. The greater the number of phenolic groups in the structure of capping agent, the better the performance against microbes.  In this domain, these finding can accelerate the use of polyphenolic compounds in biological applications in the future as antimicrobial agents. 
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Mechanistic insight into antibacterial performance of silver nanomaterials 
 
6.1  Introduction 










systems used for such purposes range from a diverse range of live organisms, particularly bacteria. Their large population sizes, rapid growth rates and simplistic maintenance make them an ideal candidate for toxicity monitoring. An additional prominent component is that bacteria can be genetically modified to respond by a detectable signal to pre-determine changes in their environmental conditions.[11-15]  Genetically engineered microorganisms have played two parallel roles in the development of toxicity bioassays, which can be referred to as “lights off” and “lights on” assays.[11] The “lights off” approach is an addition to the commonly accepted microbial toxicity bioassay, bioluminescent Vibrio fischeri. This assay is based upon measuring the decrease in light emission by microorganisms as a function of sample concentration with a short term exposure.[16] The “lights on” approach is based on the molecular combination of a reporter system to selected promoters of different stress-responsive genes. Bacterial strains have been defined to detect the presence of either specific compounds or classes of chemicals including heavy metals,[17] dioxins and endocrine disruptors[18-20] or report on the general toxicity of the selected sample.[21, 22] With this aspect, bacterial strains have also been developed for assaying genotoxicity rather than just general toxicity. In these circumstances, the promoters serving as sensors were selected from deoxyribonucleic acid (DNA) repair operons such as the SOS system.[23-26]  In this study, a double-labelled E. coli cell including a single plasmid (Figure 6.1), two inducible promoters fused to different fluorescent protein genes: recA’::EGFP and 





both genotoxicity and general toxicity to be carried out by the same reporter organism. This is the first study in which this dual reporter plasmid has been exploited to determine the genotoxicity and cytotoxicity of nanoparticles for bacterium.  
 
Figure 6.1- A schematic diagram of plasmid pNHEX:  (A) represents restriction site that can be generated using SacI and NcoI, (B) the use of MunI and NcoI and (C) MunI and NcoI.  
6.2 Experimental 
6.2.1 Electrochemical methods 





(Johnson Matthey Ultra “F” purity grade). All solutions were degassed with nitrogen for 10 minutes prior to measurements taking place. To be used as a standard to measure the degree of facile Ag nanoparticle oxidation, a polycrystalline silver (0.0317 cm2) macro electrode was also used as a working electrode. Working electrodes were cleaned via sonicating for 10 minutes in Milli-Q water and a subsequent polish using a microcloth pad (Buehler) with 0.3 µm alumina slurry (Electron Microscopy Sciences). The surface area for each nanoparticle loading was determined by analysing the charge associated with stripping of lead which has been previously deposited using under potential deposition.[27] These methods are described by Kirowa-Eisner et al. using the theoretical value of 400 µC cm-2 for full coverage of lead on silver.[28]  
6.2.2 Antibacterial applications 
6.2.2.1 Bacterial membrane protein study 






𝐾𝑑 + 𝑋 (6.1) Where Y is the fluorescence quenching, X is the concentration of nanoparticles and Bmax is the maximum binding. In this study tyrosine reduced Ag nanoparticles were not included as there is interference with the fluorescence due to its intrinsic fluorescence property in the same region of emission.  
6.2.2.2 Genotoxicity and cellular toxicity studies 






6.3 Results and discussion 
6.3.1 The oxidability for phenolic compounds and phenol-reduced 
nanoparticles 





current amplitude with increased pH.[36] The order of facile oxidation for each phytochemical is shown to follow the order EGCG < Curcumin < Tyrosine when measured in 1 M NaOH solution.  
 
Figure 6.2-Cyclic voltammograms for neat 1 M NaOH and each phenolic compound (in 1 M NaOH) used during silver nanoparticle synthesis.  Shown in Figure 6.3 is the CVs for a polycrystalline silver electrode and each silver nanoparticle modified vitreous carbon electrode. The silver electrode is used as a standard to measure the degree of facile oxidation for each of the phenolic-reduced nanoparticles that were prepared using the various molar ratios of phenolic compounds. Depicted in Figure 6.3 is the typical CV for a silver macro electrode in alkaline medium with a main peak at ca. 0.34 V with a less positive process at 0.253 V. The more positive peak with greater current response indicates the Ag0/Ag+ oxidation,[37] whilst the less positive process is associated with the oxide or hydroxide transition.[38] Figure 6.3B 
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Table 6.1 – Peak oxidation and peak reduction potential for Ag nanoparticle with phenolic coronas ordered lowest to highest. 
Peak oxidation potential (least positive to most positive) 
Curc 1:2 EGCG 1:8 Curc 1:1 EGCG 1:3 EGCG1:1 Tyr 1:1 0.273 V 0.280 V 0.288 V 0.291 V 0.293 V 0.335 V 
Peak reduction potential (most negative to least negative) 
Tyr 1:1 EGCG 1:8 Curc 1:2 Curc 1:1 EGCG 1:3 EGCG1:1 -0.017 V -0.003 V -0.002 V -0.002 V -0.002 V 0.028 V 
 
Figure 6.3 - Cyclic voltammograms for (A) polycrystalline silver and vitreous carbon electrodes modified with (B) Tyrosine-AgNPs, (C) Curcumin-AgNPs and (D) EGCG-AgNPs in 1 M NaOH. The oxide formation process for each of the nanoparticles follows from a wide double layer charging region as seen in the case of the polycrystalline silver electrode. The capacitance in this region is largest for those nanoparticles reduced using curcumin or EGCG in a 1:1 ratio to the silver salt. There is approximately the same level of activity measured for both Curc-AgNPs suggesting that the curcumin is not impeding the oxidation of underlying silver metal even at the lower relative phytochemical 
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concentration (1:2 ratio). However, there is a variance in the silver activity for the EGCG-AgNPs with the largest activity being for Ag nanoparticles synthesised using the 1:1 ratio, followed by the 1:8 and 1:3 ratios. In particular for the 1:1 EGCG-AgNPs, the less positive process displays greater current density which may be complicated due to EGCG oxidation also taking place in this region.  
6.3.2 The oxidability of various nanoparticle shapes 





Table 6.2-Peak oxidation and peak reduction potentials for shape-dependent Ag nanoparticles ordered lowest to highest. 
 
Figure 6.4- Cyclic voltammograms for Ag nanoprisms, Ag nanocubes and Ag nanospheres. 
 
6.3.3 Comparison of oxidation potentials dependent on corona or shape 
with antibacterial activity. 
When comparing all of the AgNPs it is clear to see that capping of the nanoparticles still facilitates silver activity (REDOX) which, when ordered according to peak oxidation potentials fits quite well with antibacterial activity results against both Gram negative and Gram positive bacteria, shown in Table 6.3. Thus the choice of phenolic compounds for silver reduction, and nanoparticle capping, can be used to tailor the effectiveness of antibacterial activity of these platforms. 
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Peak oxidation potential (least positive to most positive)(V) 
Ag prisms Ag cubes Ag spheres 0.299 0.305 0.335 
Peak reduction potential (most negative to least negative) 





Table 6.3- Comparison of antibacterial activity and oxidation potentials for each nanoparticle synthesised including the use of phenolic compounds with varying molar ratios. Antibacterial data refers to the lowest concentration loading.  
Antibacterial activity of nanoparticles against E. coli (%) 
Curc 1:2 EGCG 1:8 EGCG 1:3 EGCG 1:1 Curc 1:1 Ag cubes Ag spheres Ag prisms 68 67 67 49 46 39 33 17 
Oxidation potential for each nanoparticle (least to most positive) (V) 
Curc 1:2 EGCG 1:8 Curc 1:1 EGCG 1:3 EGCG 1:1 Ag prisms  Ag cubes  Ag spheres 0.273 0.280 0.288 0.291 0.293 0.299 0.305 0.335 
Antibacterial activity of nanoparticles against S. albus (%) 










Ag nanocubes synthesised via a polyol process used polyvinylpyrrolidone (PVP) as a stabilising agent.[45] PVP is a common stabilising ingredient in the production of Ag nanoparticles.[46, 47] Not only is PVP utilised in various synthesises, it is also known as an antimicrobial agent, namely Betadine. It is a broad spectrum antiseptic for topical application in the treatment of burn and wounds.[48]  
6.3.4  Interaction of nanoparticles with bacterial membrane proteins 











strong membrane protein interaction. Plausible explanation to this is that EGCG is a more bulky molecule than curcumin and may interact strongly with secondary and tertiary protein structures in comparison to curcumin.[49, 50] While antibacterial activity is attributed to several mechanisms, membrane protein interaction is only one of those mechanisms. Genotoxicity (DNA damage), cytotoxicity (protein damage), production of reactive oxygen species etc. are other mechanism of bacterial cell death mediated by nanoparticles.[51-53] Curc-AgNPs demonstrated 30 fold more affinity (Kd) against SAMP (1.59 µM) in comparison to EGCG-AgNPs (50.5 µM). This evinces that curcumin possesses a slow off rate for SAMP over ECMP in terms of membrane protein binding. In general these results show that EGCG-AgNPs have high affinity for ECMP (Gram negative) over SAMP (Gram positive) while this trend is reverse in case of Curc-AgNPs. This is also evident in a study by Hamed et al.  which shows potent activity of curcumin itself in the case of Gram positive bacteria.[54]  
 
Figure 6.6- Dissociation constant (Kd) of (A) ECMP and (B) SAMP profiles. 
6.3.5 Genotoxicity and cellular detection  





Curc-AgNPs at 1:2 and EGCG-AgNPs at 1:8 ratios were used as they displayed the highest antibacterial activity. In this experiment ethanol, a known inducer of heat shock response (cellular stress or cytotoicity) and nalidixic acid an accepted inducer of SOS response were used as a positive control.  As demonstrated in Figure 6.7, the presence of nanoparticles regardless of their capping material induces expression of GFP, thus this confirms the genotoxic nature (DNA damaging potential). Furthermore when bacterium is exposed to nanoparticles and the expression of RFP was monitored, induction of RFP expression in presence of Curc-AgNPs was significantly higher than ethanol. Other nanoparticles (EGCG-AgNPs and Tyr-AgNPs) also displayed induction of RFP however it was less than the Curc-AgNPs induced expression. This suggests that all nanomaterials have the same genotoxicity potential but Curc-AgNPs induces highest stress response or cytotoxicity. 
 
Figure 6.7- (A) GFP fluorescence profile and (B) RFP fluorescence profile. 
6.4 Conclusions 










Therefore, this reveals that Curc-AgNPs possess a slow off rate for SAMP over ECMP in terms of membrane protein binding.   Since Curc-AgNPs 1:2 and EGCG-AgNPs 1:8 demonstrated the highest antibacterial activity, the genotoxicity and cellular toxicity were studied on these two systems. When bacterium is exposed to Ag nanomaterials, significant induction of RFP expression in presence of Curc-AgNPs 1:2 displayed the highest stress response. For GFP response (genotoxicity) irrespective of capping agents, Ag nanomaterials induce expressions of GFP which confirms DNA damage and SOS response. These properties are illustrated in Figure 6.8.  
 
Figure 6.8- Schematic illustration of potential mechanisms of antibacterial activity of functionalised Ag nanoparticles against E. coli and S. albus based upon genotoxicity and genotoxicity data. 





seems that irrespective of mode of action, a measure of oxidisation potential via cyclic voltammetry can in general be considered a reliable tool to predict the effectiveness of Ag nanomaterials antibacterial activity.  
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Conclusions and future work 
7.1  Conclusions 




















Overall, various methods including electrochemical, biophysical and biotechnological approaches were employed to elucidate the mechanism of action of Ag nanostructures as demonstrated in this thesis.  
7.2  Future work 





Gram negative targeting compounds, both broad and narrow spectrum. It will also be interesting to measure the synergism of antibiotics with the nanomaterials of different shapes, as well as functionalised nanospheres discussed within this thesis.  All the materials proposed in this thesis may also be studied for their antimicrobial activity against other group of microorganisms including fungi for antifungal activity. It will also be prudent to study whether these nanomaterials can be utilised in other biotechnological applications such as cytotoxicity towards mammalian cells not just microorganisms.   In summary, the work presented in this thesis clearly shows that the mode of antibacterial activity of Ag based nanomaterials is a highly complex phenomenon. This involves several steps including (i) level of interaction of nanomaterial with bacterial outer layer, (ii) uptake of nanoparticles by cell, (iii) potential oxidation of Ag nanoparticles to Ag+ ions and (iv) interaction of Ag+ ions with bacterial cellular, cytoplasmic and genetic components. This thesis shows that all these mechanistic components can be controlled by tailor-design of nanoparticles through shape control, surface control or synergism through traditional antibiotics. It is expected that these research outcomes will fuel more research in understanding the antibacterial activity of Ag based nanomaterials.   
